Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coregulator activity	BCL9L NCOA3 TCF4 NCOA6 HDAC4 HIPK1 EID2B BCL9 RUVBL2 ZIC3 ARID1B KMT2D TLE3 TOX3 EID1 MED23	2.83e-06	562	143	16	GO:0003712
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	NCOA3 TCF4 TBX21 ASCL5 ATF6B ZEB2 MEIS1 MEIS2 ZIC3 KMT2D TP63 BARHL2 ZNF91 ONECUT3 FOXF1	1.22e-05	560	143	15	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	NCOA3 TCF4 TBX21 ASCL5 ATF6B ZEB2 MEIS1 MEIS2 ZIC3 KMT2D TP63 BARHL2 ZNF91 ONECUT3 FOXF1	1.38e-05	566	143	15	GO:0001216
GeneOntologyMolecularFunction	molecular adaptor activity	BCL9L NCOA3 TCF4 NCOA6 HDAC4 OFD1 HIPK1 ITSN1 EID2B AMBRA1 BCL9 RUVBL2 ST13 KCTD17 ZIC3 ARID1B KMT2D TLE3 ITSN2 TOX3 EID1 ZNF91 MED23	9.51e-05	1356	143	23	GO:0060090
GeneOntologyMolecularFunction	profilin binding	PCLO DBN1 ENAH	9.76e-05	13	143	3	GO:0005522
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	BCL9L NCOA3 TCF4 NCOA6 HDAC4 HIPK1 EID2B AMBRA1 BCL9 RUVBL2 ST13 KCTD17 ZIC3 ARID1B KMT2D TLE3 TOX3 EID1 ZNF91 MED23	2.30e-04	1160	143	20	GO:0030674
GeneOntologyMolecularFunction	transcription coactivator activity	BCL9L NCOA3 NCOA6 BCL9 ZIC3 ARID1B KMT2D TOX3 MED23	3.42e-04	303	143	9	GO:0003713
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	KMT2B KMT2D SETBP1	3.75e-04	20	143	3	GO:0042800
GeneOntologyMolecularFunction	tRNA (cytidine-5-)-methyltransferase activity	NSUN4 NSUN6	5.02e-04	5	143	2	GO:0016428
GeneOntologyMolecularFunction	dATP binding	ST13 ST13P5	5.02e-04	5	143	2	GO:0032564
GeneOntologyMolecularFunction	adenyl deoxyribonucleotide binding	ST13 ST13P5	7.50e-04	6	143	2	GO:0032558
GeneOntologyMolecularFunction	purine deoxyribonucleotide binding	ST13 ST13P5	1.04e-03	7	143	2	GO:0032554
GeneOntologyMolecularFunction	transcription corepressor activity	TCF4 HDAC4 HIPK1 EID2B RUVBL2 TLE3 EID1	1.33e-03	229	143	7	GO:0003714
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	KMT2B KMT2D	1.39e-03	8	143	2	GO:0140945
GeneOntologyMolecularFunction	S-adenosylmethionine-dependent methyltransferase activity	NSUN4 KMT2B NSUN6 KMT2D SETBP1 PRMT7	1.51e-03	172	143	6	GO:0008757
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	NCOA3 TCF4 HDAC4 TBX21 ASCL5 RUVBL2 ATF6B ZEB2 MEIS1 MEIS2 HSF5 ZIC3 STK16 BBX TP63 BARHL2 ZFHX3 ZNF91 ONECUT3 ZNF98 FOXF1	1.67e-03	1459	143	21	GO:0000977
GeneOntologyMolecularFunction	histone methyltransferase activity	KMT2B KMT2D SETBP1 PRMT7	1.69e-03	71	143	4	GO:0042054
GeneOntologyMolecularFunction	beta-catenin binding	BCL9L TCF4 AMER1 BCL9 RUVBL2	1.73e-03	120	143	5	GO:0008013
GeneOntologyMolecularFunction	deoxyribonucleotide binding	ST13 ST13P5	1.77e-03	9	143	2	GO:0032552
GeneOntologyMolecularFunction	tRNA (cytidine) methyltransferase activity	NSUN4 NSUN6	2.21e-03	10	143	2	GO:0016427
GeneOntologyMolecularFunction	histone H3K4 trimethyltransferase activity	KMT2B KMT2D	2.21e-03	10	143	2	GO:0140999
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	BCL9L NCOA3 TCF4 NCOA6 HDAC4 TBX21 ASCL5 BCL9 RUVBL2 ATF6B ZEB2 MEIS1 MEIS2 ZIC3 STK16 ZNF462 KMT2D CSF3 TP63 BARHL2 TOX3 ZFHX3 CHD6 ZNF91 ONECUT3 MED23 FOXF1	8.23e-07	1390	142	27	GO:0045944
GeneOntologyCellularComponent	beta-catenin-TCF complex	BCL9L TCF4 BCL9 TLE3	1.43e-06	13	143	4	GO:1990907
GeneOntologyCellularComponent	transcription regulator complex	BCL9L NCOA3 TCF4 NCOA6 HDAC4 ASCL5 BCL9 ATF6B MEIS1 GTF3C2 TLE3 ZFHX3 ONECUT3 MED23 FOXF1	1.49e-05	596	143	15	GO:0005667
GeneOntologyCellularComponent	postsynaptic actin cytoskeleton	ITSN1 DBN1 KPTN	2.80e-04	19	143	3	GO:0098871
HumanPheno	Short fourth metatarsal	TCF4 HDAC4 CDC42BPB ITPR1 PRMT7	4.43e-07	16	54	5	HP:0004689
HumanPheno	Abnormality of the fourth metatarsal bone	TCF4 HDAC4 CDC42BPB ITPR1 PRMT7	4.43e-07	16	54	5	HP:0040035
HumanPheno	Abnormality of dental eruption	TCF4 MIA3 AMER1 HDAC4 TRIO ZEB2 SEC24D ARID1B KMT2D TP63 SETBP1 CHD6	5.34e-06	240	54	12	HP:0006292
HumanPheno	Ankyloglossia	COL7A1 OFD1 CDC42BPB KMT2D SETBP1	1.09e-05	29	54	5	HP:0010296
HumanPheno	Delayed speech and language development	POMT2 CACNA1E TCF4 AMPD2 AMER1 KMT2B HDAC4 OFD1 TRIO WDR81 ZEB2 MEIS2 OPHN1 ITPR1 KPTN ZNF462 ACSL4 ARID1B NSUN6 KMT2D TP63 SETBP1 TRAPPC10 MED23 PRMT7 MN1	1.86e-05	1123	54	26	HP:0000750
HumanPheno	Abnormal nasal tip morphology	TCF4 KMT2B HDAC4 OFD1 TRIO CDC42BPB ZEB2 KPTN ZNF462 ARID1B KMT2D TP63 SETBP1 PRMT7	3.19e-05	386	54	14	HP:0000436
HumanPheno	Dilatation of the renal pelvis	MIA3 HDAC4 OFD1 LAMB3 CDC42BPB ZEB2 ZIC3 ARID1B KMT2D TP63 SETBP1 FOXF1	3.66e-05	290	54	12	HP:0010946
HumanPheno	Abnormality of the palpebral fissures	TCF4 AMPD2 HDAC4 OFD1 TRIO PCLO CDC42BPB ZEB2 MEIS2 ITPR1 KPTN ZNF462 ACSL4 SEC24D ARID1B KMT2D TP63 SETBP1 TRAPPC10 HSD17B4 PRMT7 MN1	3.78e-05	880	54	22	HP:0008050
HumanPheno	Language impairment	POMT2 CACNA1E TCF4 AMPD2 AMER1 KMT2B HDAC4 OFD1 TRIO WDR81 ZEB2 MEIS2 OPHN1 ITPR1 KPTN ZNF462 ACSL4 ARID1B NSUN6 KMT2D TP63 SETBP1 TRAPPC10 MED23 PRMT7 MN1	4.52e-05	1178	54	26	HP:0002463
HumanPheno	Abnormal renal pelvis morphology	MIA3 HDAC4 OFD1 LAMB3 CDC42BPB ZEB2 ZIC3 ARID1B KMT2D TP63 SETBP1 FOXF1	5.11e-05	300	54	12	HP:0010944
HumanPheno	Aplasia/Hypoplasia of metatarsal bones	TCF4 HDAC4 CDC42BPB ITPR1 TP63 PRMT7	5.96e-05	66	54	6	HP:0001964
HumanPheno	Hydronephrosis	MIA3 HDAC4 OFD1 LAMB3 ZEB2 ZIC3 ARID1B KMT2D TP63 SETBP1 FOXF1	7.68e-05	264	54	11	HP:0000126
HumanPheno	Intellectual disability, severe	POMT2 TCF4 KMT2B OFD1 WDR81 ZEB2 OPHN1 ITPR1 ACSL4 ARID1B SETBP1 TRAPPC10 PRMT7	9.33e-05	371	54	13	HP:0010864
HumanPheno	Retrognathia	MIA3 AMER1 KMT2B OFD1 TRIO KPTN SEC24D ARID1B KMT2D SETBP1 HSD17B4 PRMT7 FOXF1	1.04e-04	375	54	13	HP:0000278
HumanPheno	Bilirubinuria	SLCO1B3 SLCO1B1	1.10e-04	2	54	2	HP:0031811
HumanPheno	Frontal bossing	AMER1 KMT2B HDAC4 OFD1 TRIO CDC42BPB ZEB2 MEIS2 OPHN1 ITPR1 KPTN SEC24D ARID1B KMT2D TP63 SETBP1 CHD6 HSD17B4 PRMT7	1.12e-04	738	54	19	HP:0002007
HumanPheno	Slanting of the palpebral fissure	TCF4 AMPD2 HDAC4 OFD1 TRIO CDC42BPB ZEB2 MEIS2 ITPR1 KPTN ZNF462 ACSL4 SEC24D ARID1B KMT2D SETBP1 TRAPPC10 HSD17B4 MN1	1.14e-04	739	54	19	HP:0200006
HumanPheno	Delayed eruption of teeth	TCF4 MIA3 AMER1 HDAC4 TRIO ZEB2 SEC24D ARID1B SETBP1	1.17e-04	185	54	9	HP:0000684
HumanPheno	Abnormal shape of the frontal region	AMER1 KMT2B HDAC4 OFD1 TRIO CDC42BPB ZEB2 MEIS2 OPHN1 ITPR1 KPTN SEC24D ARID1B KMT2D TP63 SETBP1 CHD6 HSD17B4 PRMT7	1.19e-04	741	54	19	HP:0011218
HumanPheno	Abnormal frontal bone morphology	AMER1 KMT2B HDAC4 OFD1 TRIO CDC42BPB ZEB2 MEIS2 OPHN1 ITPR1 KPTN SEC24D ARID1B KMT2D TP63 SETBP1 CHD6 HSD17B4 PRMT7	1.21e-04	742	54	19	HP:0430000
HumanPheno	Abnormal eyelid morphology	TCF4 AMPD2 AMER1 KMT2B HDAC4 OFD1 TRIO PCLO CDC42BPB ZEB2 MEIS2 KCTD17 ITPR1 KPTN ZNF462 ACSL4 SEC24D ZNF469 ARID1B KMT2D TP63 SETBP1 TRAPPC10 DSG4 CHD6 HSD17B4 PRMT7 MN1	1.33e-04	1408	54	28	HP:0000492
HumanPheno	Abnormality of the dentition	TCF4 COL7A1 MIA3 AMER1 HDAC4 OFD1 TRIO LAMB3 CDC42BPB ZEB2 MEIS2 ITPR1 ACSL4 SEC24D ZNF469 ARID1B KMT2D TP63 SETBP1 AGXT DSG4 CHD6 PRMT7	1.43e-04	1030	54	23	HP:0000164
HumanPheno	Deviation of the hand or of fingers of the hand	TCF4 MIA3 AMER1 KMT2B HDAC4 OFD1 TRIO ZEB2 ZIC3 KPTN ZNF462 ARID1B KMT2D TP63 SETBP1 CHD6	1.55e-04	564	54	16	HP:0009484
HumanPheno	Sparse eyebrow	TCF4 HDAC4 CDC42BPB MEIS2 KMT2D TP63 DSG4 CHD6	1.62e-04	151	54	8	HP:0045075
HumanPheno	Abnormal midface morphology	TCF4 AMPD2 KMT2B HDAC4 OFD1 TRIO PCLO CDC42BPB ZNF462 ACSL4 SEC24D ARID1B KMT2D TP63 SETBP1 CHD6 PRMT7 MN1	2.01e-04	704	54	18	HP:0000309
HumanPheno	Abnormality of the forehead	POMT2 TCF4 AMPD2 AMER1 KMT2B HDAC4 OFD1 TRIO CDC42BPB ZEB2 MEIS2 OPHN1 ITPR1 KPTN ZNF462 SEC24D ARID1B KMT2D TP63 SETBP1 TRAPPC10 CHD6 HSD17B4 PRMT7 MN1	2.16e-04	1208	54	25	HP:0000290
HumanPheno	Abnormal palm morphology	TCF4 COL7A1 KMT2B HDAC4 TRIO DSG1 WDR81 LAMB3 CDC42BPB ZNF462 ZNF469 ARID1B KMT2D TP63 SETBP1	2.26e-04	521	54	15	HP:0100871
HumanPheno	Aplasia/Hypoplasia involving bones of the feet	TCF4 MIA3 HDAC4 OFD1 WDR81 CDC42BPB ITPR1 ARID1B TP63 CHD6 PRMT7	2.27e-04	298	54	11	HP:0006494
HumanPheno	Deficiency of speech development	POMT2 CACNA1E TCF4 AMPD2 HDAC4 OFD1 TRIO ZEB2 OPHN1 ARID1B TP63 SETBP1 TRAPPC10 MED23	2.32e-04	463	54	14	HP:0002116
HumanPheno	Supernumerary tooth	AMER1 OFD1 ACSL4 KMT2D TP63 CHD6	2.46e-04	85	54	6	HP:0011069
HumanPheno	Highly arched eyebrow	HDAC4 OFD1 TRIO CDC42BPB ZEB2 MEIS2 ZNF462 KMT2D MN1	2.65e-04	206	54	9	HP:0002553
HumanPheno	Congenital malformation of the great arteries	AMER1 KMT2B HDAC4 OFD1 TRIO CDC42BPB ZEB2 ZIC3 ITPR1 ZNF462 ACSL4 ARID1B KMT2D TP63 FOXF1	2.67e-04	529	54	15	HP:0011603
HumanPheno	Delayed ability to walk	AMPD2 HDAC4 TRIO WDR81 ZEB2 OPHN1 ITPR1 KPTN ARID1B TRAPPC10 PRMT7	2.70e-04	304	54	11	HP:0031936
HumanPheno	Abnormal skin morphology of the palm	TCF4 COL7A1 HDAC4 TRIO DSG1 LAMB3 CDC42BPB ZNF462 ZNF469 ARID1B KMT2D TP63 SETBP1	2.76e-04	413	54	13	HP:0040211
HumanPheno	Lip pit	OFD1 KMT2D TP63	2.99e-04	13	54	3	HP:0100267
HumanPheno	Abnormal hand morphology	TCF4 COL7A1 MIA3 AMER1 KMT2B HDAC4 OFD1 TRIO WDR81 LAMB3 CDC42BPB ZEB2 MEIS2 ZIC3 KPTN ZNF462 ARID1B KMT2D TP63 SETBP1 CHD6 HSD17B4 PRMT7	3.10e-04	1082	54	23	HP:0005922
HumanPheno	Deviation of finger	TCF4 MIA3 AMER1 KMT2B HDAC4 OFD1 TRIO ZIC3 KPTN ZNF462 ARID1B KMT2D TP63 SETBP1 CHD6	3.15e-04	537	54	15	HP:0004097
HumanPheno	Thin corpus callosum	POMT2 CACNA1E TCF4 AMPD2 AMER1 HDAC4 OFD1 PCLO WDR81 CDC42BPB ZEB2 ITPR1 ZNF462 ARID1B KMT2D SETBP1 TRAPPC10 HSD17B4 MED23 PRMT7	3.25e-04	868	54	20	HP:0033725
HumanPheno	Intellectual disability, mild	POMT2 MIA3 AMER1 KMT2B TRIO ITPR1 ZNF462 ARID1B KMT2D SETBP1 HSD17B4 PRMT7	3.33e-04	365	54	12	HP:0001256
HumanPheno	Motor delay	POMT2 TCF4 AMPD2 KMT2B HDAC4 OFD1 TRIO WDR81 ZEB2 OPHN1 ITPR1 KPTN ZNF462 SEC24D ARID1B NSUN6 KMT2D SETBP1 TRAPPC10 HSD17B4 PRMT7 MN1	3.58e-04	1018	54	22	HP:0001270
HumanPheno	Short metatarsal	TCF4 HDAC4 CDC42BPB ITPR1 PRMT7	4.54e-04	62	54	5	HP:0010743
HumanPheno	Absent speech	POMT2 CACNA1E TCF4 AMPD2 HDAC4 OFD1 TRIO ZEB2 OPHN1 ARID1B SETBP1 TRAPPC10 MED23	4.69e-04	436	54	13	HP:0001344
HumanPheno	Patent ductus arteriosus	AMER1 KMT2B HDAC4 TRIO CDC42BPB ZEB2 ZIC3 ACSL4 ARID1B KMT2D TP63 FOXF1	5.06e-04	382	54	12	HP:0001643
HumanPheno	Sparse hair	KMT2B HDAC4 OFD1 DSG1 LAMB3 CDC42BPB ARID1B KMT2D TP63 DSG4 CHD6 PRMT7	5.19e-04	383	54	12	HP:0008070
HumanPheno	Multicystic kidney dysplasia	AMER1 HDAC4 OFD1 LAMB3 ZEB2 KMT2D	5.33e-04	98	54	6	HP:0000003
HumanPheno	Thick vermilion border	TCF4 AMER1 HDAC4 OFD1 TRIO ZEB2 ACSL4 ARID1B KMT2D SETBP1	5.77e-04	279	54	10	HP:0012471
HumanPheno	Abnormal 5th finger morphology	MIA3 AMER1 KMT2B HDAC4 OFD1 TRIO MEIS2 KPTN ZNF462 ARID1B KMT2D TP63 SETBP1 CHD6	6.18e-04	509	54	14	HP:0004207
HumanPheno	Abnormality of the curvature of the cornea	TCF4 KMT2B HDAC4 OFD1 ARHGEF18 ZEB2 ITPR1 ZNF469 ARID1B SETBP1 PRMT7	6.39e-04	336	54	11	HP:0100691
HumanPheno	Finger clinodactyly	TCF4 MIA3 AMER1 KMT2B HDAC4 OFD1 TRIO KPTN ZNF462 ARID1B KMT2D TP63 CHD6	6.64e-04	452	54	13	HP:0040019
HumanPheno	Milia	COL7A1 OFD1 LAMB3	6.89e-04	17	54	3	HP:0001056
HumanPheno	Underdeveloped nasal alae	HDAC4 OFD1 TRIO KMT2D TP63 CHD6	7.31e-04	104	54	6	HP:0000430
HumanPheno	Abnormality of hair density	KMT2B HDAC4 OFD1 DSG1 LAMB3 CDC42BPB ARID1B KMT2D TP63 DSG4 CHD6 PRMT7	7.34e-04	398	54	12	HP:0011357
HumanPheno	Abnormal oral frenulum morphology	COL7A1 OFD1 CDC42BPB KMT2D SETBP1	7.96e-04	70	54	5	HP:0000190
HumanPheno	Abnormality of corneal size	POMT2 TCF4 KMT2B HDAC4 OFD1 ARHGEF18 ZEB2 ITPR1 ZNF469 ARID1B KMT2D SETBP1 PRMT7	8.01e-04	461	54	13	HP:0001120
HumanPheno	Ventriculomegaly	POMT2 TCF4 AMPD2 HDAC4 OFD1 WDR81 CDC42BPB ZEB2 OPHN1 ITPR1 KPTN ZNF462 ARID1B KMT2D SETBP1 TRAPPC10 HSD17B4 FOXF1	8.52e-04	790	54	18	HP:0002119
HumanPheno	Pruritus	TCF4 COL7A1 MIA3 SLCO1B3 SLCO1B1 ZEB2 DSG4	8.89e-04	149	54	7	HP:0000989
HumanPheno	Abnormal corpus callosum morphology	POMT2 CACNA1E TCF4 AMPD2 AMER1 HDAC4 OFD1 PCLO WDR81 CDC42BPB ZEB2 ITPR1 ZNF462 ARID1B KMT2D SETBP1 TRAPPC10 HSD17B4 MED23 PRMT7	9.10e-04	937	54	20	HP:0001273
HumanPheno	Abnormal fetal gastrointestinal system morphology	ZIC3 KMT2D HSD17B4	9.68e-04	19	54	3	HP:0034207
HumanPheno	Abnormality of globe location or size	POMT2 TCF4 AMER1 KMT2B HDAC4 OFD1 TRIO PCLO CDC42BPB ZEB2 MEIS2 OPHN1 ZIC3 KPTN ZNF462 SEC24D ARID1B KMT2D SETBP1 CHD6 HSD17B4 PRMT7 MN1 FOXF1	9.81e-04	1246	54	24	HP:0000489
Domain	BCL9	BCL9L BCL9	5.58e-05	2	140	2	PF11502
Domain	Bcl-9	BCL9L BCL9	5.58e-05	2	140	2	IPR015668
Domain	BCL9_beta-catenin-bd_dom	BCL9L BCL9	5.58e-05	2	140	2	IPR024670
Domain	PH_13	ITSN1 ITSN2	5.58e-05	2	140	2	PF16652
Domain	EH	SYNRG ITSN1 ITSN2	6.51e-05	11	140	3	PS50031
Domain	EH	SYNRG ITSN1 ITSN2	6.51e-05	11	140	3	SM00027
Domain	EH_dom	SYNRG ITSN1 ITSN2	6.51e-05	11	140	3	IPR000261
Domain	RhoGEF	TRIO ITSN1 ARHGEF18 ITSN2 VAV2	1.57e-04	68	140	5	SM00325
Domain	EID	EID2B EID1	1.67e-04	3	140	2	IPR033258
Domain	RhoGEF	TRIO ITSN1 ARHGEF18 ITSN2 VAV2	1.80e-04	70	140	5	PF00621
Domain	DH_2	TRIO ITSN1 ARHGEF18 ITSN2 VAV2	1.80e-04	70	140	5	PS50010
Domain	-	TRIO ITSN1 ARHGEF18 ITSN2 VAV2	1.93e-04	71	140	5	1.20.900.10
Domain	DH-domain	TRIO ITSN1 ARHGEF18 ITSN2 VAV2	1.93e-04	71	140	5	IPR000219
Domain	Desmoglein	DSG1 DSG4	3.31e-04	4	140	2	IPR009123
Domain	PH_dom-like	TRIO ITSN1 FRMPD1 APBA2 ARHGEF18 CDC42BPB OPHN1 TYK2 ITSN2 ENAH VAV2	3.72e-04	426	140	11	IPR011993
Domain	FYrich_C	KMT2B KMT2D	5.50e-04	5	140	2	IPR003889
Domain	FYrich_N	KMT2B KMT2D	5.50e-04	5	140	2	IPR003888
Domain	FYRC	KMT2B KMT2D	5.50e-04	5	140	2	SM00542
Domain	FYRN	KMT2B KMT2D	5.50e-04	5	140	2	SM00541
Domain	PKNOX/Meis_N	MEIS1 MEIS2	5.50e-04	5	140	2	IPR032453
Domain	FYRN	KMT2B KMT2D	5.50e-04	5	140	2	PF05964
Domain	FYRC	KMT2B KMT2D	5.50e-04	5	140	2	PF05965
Domain	FYRC	KMT2B KMT2D	5.50e-04	5	140	2	PS51543
Domain	FYRN	KMT2B KMT2D	5.50e-04	5	140	2	PS51542
Domain	Meis_PKNOX_N	MEIS1 MEIS2	5.50e-04	5	140	2	PF16493
Domain	HMG_box	KMT2D PBRM1 BBX TOX3	6.66e-04	53	140	4	PF00505
Domain	HMG	KMT2D PBRM1 BBX TOX3	7.15e-04	54	140	4	SM00398
Domain	WD40	WDR33 WDR81 AMBRA1 THOC3 FBXW8 GTF3C2 TLE3 PRPF19	7.59e-04	259	140	8	PF00400
Domain	-	KMT2D PBRM1 BBX TOX3	7.67e-04	55	140	4	1.10.30.10
Domain	GATASE_TYPE_1	PFAS CTPS2	8.20e-04	6	140	2	PS51273
Domain	NOL1_NOP2_SUN	NSUN4 NSUN6	8.20e-04	6	140	2	PS01153
Domain	RCMT	NSUN4 NSUN6	8.20e-04	6	140	2	IPR023267
Domain	GATASE	PFAS CTPS2	8.20e-04	6	140	2	IPR017926
Domain	-	PCLO ITSN1 RAB11FIP1 C2CD2L ITSN2 CCDC33	8.78e-04	148	140	6	2.60.40.150
Domain	WD40	WDR33 WDR81 AMBRA1 THOC3 FBXW8 GTF3C2 TLE3 PRPF19	9.47e-04	268	140	8	SM00320
Domain	WD40_repeat	WDR33 WDR81 AMBRA1 THOC3 FBXW8 GTF3C2 TLE3 PRPF19	1.04e-03	272	140	8	IPR001680
Domain	Desmosomal_cadherin	DSG1 DSG4	1.14e-03	7	140	2	IPR009122
Domain	SAM_MT_RSMB_NOP	NSUN4 NSUN6	1.14e-03	7	140	2	PS51686
Domain	WD_REPEATS_1	WDR33 WDR81 AMBRA1 THOC3 FBXW8 GTF3C2 TLE3 PRPF19	1.20e-03	278	140	8	PS00678
Domain	WD_REPEATS_2	WDR33 WDR81 AMBRA1 THOC3 FBXW8 GTF3C2 TLE3 PRPF19	1.22e-03	279	140	8	PS50082
Domain	WD_REPEATS_REGION	WDR33 WDR81 AMBRA1 THOC3 FBXW8 GTF3C2 TLE3 PRPF19	1.22e-03	279	140	8	PS50294
Domain	DH_1	TRIO ITSN1 ARHGEF18 VAV2	1.28e-03	63	140	4	PS00741
Domain	HMG_box_dom	KMT2D PBRM1 BBX TOX3	1.44e-03	65	140	4	IPR009071
Domain	C2_dom	PCLO ITSN1 RAB11FIP1 C2CD2L ITSN2 CCDC33	1.49e-03	164	140	6	IPR000008
Domain	MeTrfase_RsmB/NOP2	NSUN4 NSUN6	1.52e-03	8	140	2	IPR001678
Domain	Methyltr_RsmB-F	NSUN4 NSUN6	1.52e-03	8	140	2	PF01189
Domain	PH	TRIO ITSN1 ARHGEF18 CDC42BPB OPHN1 ITSN2 VAV2	1.72e-03	229	140	7	PF00169
Domain	WD40_repeat_dom	WDR33 WDR81 AMBRA1 THOC3 FBXW8 GTF3C2 TLE3 PRPF19	1.82e-03	297	140	8	IPR017986
Domain	MIR	POMT2 ITPR1	2.41e-03	10	140	2	PF02815
Domain	-	PFAS CTPS2	2.41e-03	10	140	2	3.40.50.880
Domain	STI1	ST13 ST13P5	2.41e-03	10	140	2	SM00727
Domain	MIR_motif	POMT2 ITPR1	2.41e-03	10	140	2	IPR016093
Domain	MIR	POMT2 ITPR1	2.41e-03	10	140	2	PS50919
Domain	MIR	POMT2 ITPR1	2.41e-03	10	140	2	SM00472
Domain	EF-hand_4	ITSN1 ITSN2	2.41e-03	10	140	2	PF12763
Domain	STI1_HS-bd	ST13 ST13P5	2.41e-03	10	140	2	IPR006636
Domain	Kazal_2	SLCO1B3 SLCO1B1 WFIKKN1	2.46e-03	36	140	3	PF07648
Domain	-	TRIO ITSN1 APBA2 ARHGEF18 CDC42BPB OPHN1 ITSN2 ENAH VAV2	2.78e-03	391	140	9	2.30.29.30
Pathway	REACTOME_CDC42_GTPASE_CYCLE	TRIO ITSN1 PAK5 WDR81 GIT2 CDC42BPB OPHN1 VAV2	2.31e-05	155	107	8	M41808
Pathway	REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX	BCL9L BCL9 KMT2D TLE3	4.12e-05	26	107	4	MM14793
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KIF13B GPRASP1 CACNA1E NCOA3 AMPD2 MIA3 HDAC4 TRIO ITSN1 PAK5 HNRNPM WDR81 ARHGEF18 GIT2 DBN1 BCL9 CDC42BPB ATF6B ZEB2 KHSRP ZNF462 EEF2 PBRM1 NCAN ENAH AFDN	3.00e-14	963	144	26	28671696
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	NCOA3 HNRNPM RUVBL2 KHSRP ZNF462 ARID1B KMT2D PBRM1 PRPF19 ZFHX3 MED23 PSPC1	1.51e-10	220	144	12	35785414
Pubmed	Interaction network of human early embryonic transcription factors.	BCL9L NCOA3 NCOA6 KMT2B HDAC4 BCL9 ZEB2 ZNF462 ARID1B KMT2D PBRM1 TLE3 ZFHX3	2.90e-09	351	144	13	38297188
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	GPRASP1 BCL9L SYNRG AMPD2 MIA3 TRIO DSG1 PCLO HNRNPM APBA2 DBN1 RUVBL2 CDC42BPB ST13 KHSRP ITPR1 C2CD2L ENAH AFDN ST13P5 SLC16A7	1.08e-08	1139	144	21	36417873
Pubmed	Human transcription factor protein interaction networks.	BCL9L NCOA3 TCF4 NCOA6 KMT2B OFD1 WDR33 MRPL10 DBN1 BCL9 RUVBL2 ZEB2 ZIC3 ZNF462 ARID1B KMT2D PBRM1 BBX GTF3C2 TLE3 PRPF19 ZFHX3 CHD6	2.48e-08	1429	144	23	35140242
Pubmed	A census of human transcription factors: function, expression and evolution.	NCOA3 TCF4 TBX21 ATF6B ZEB2 MEIS1 MEIS2 HSF5 KMT2D BBX TP63 BARHL2 SETBP1 TOX3 ZFHX3 ZNF91 ONECUT3 FOXF1	4.50e-08	908	144	18	19274049
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	BCL9L AMPD2 MIA3 AMER1 HDAC4 OFD1 DBN1 RAB11FIP1 RUVBL2 ARID1B MOB1B TRAPPC10 AFDN	4.90e-08	446	144	13	24255178
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA3 NCOA6 BCL9 ARID1B KMT2D TLE3 TP63	5.75e-08	83	144	7	28794006
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	NCOA6 KMT2B HDAC4 RUVBL2 ARID1B KMT2D PBRM1 CHD6	3.23e-07	157	144	8	30186101
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	TCF4 ST13 ZEB2 PBRM1 BBX CHD6 ST13P5	3.77e-07	109	144	7	33554859
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOA3 NCOA6 MRPL10 TBC1D25 BCL9 ACSL4 RNF123 ARID1B KMT2D PBRM1 TLE3 ITSN2 DSG4 CHD6	4.68e-07	638	144	14	31182584
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SYNRG NCOA6 KMT2B WDR33 DBN1 RUVBL2 KHSRP ARID1B KMT2D GTF3C2 ENAH AFDN MED23	5.26e-07	549	144	13	38280479
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	CACNA1E HDAC4 TRIO DSG1 INTS7 OPHN1 KHSRP ITPR1 EEF2 PBRM1 CHD6 HSD17B4	7.47e-07	475	144	12	31040226
Pubmed	Functional proteomics mapping of a human signaling pathway.	NCOA6 KMT2B HIPK1 ITSN1 ST13 ZEB2 SEC24D RNF123 ARID1B KMT2D PBRM1 AFDN CHD6	1.19e-06	591	144	13	15231748
Pubmed	Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases.	NCOA6 KMT2B KMT2D	1.38e-06	6	144	3	17021013
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	BCL9L NCOA3 NCOA6 WDR33 BCL9 ARID1B KMT2D PBRM1 TLE3	1.92e-06	268	144	9	33640491
Pubmed	ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity.	NCOA6 KMT2B KMT2D	2.40e-06	7	144	3	19556342
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	BCL9L NCOA3 NCOA6 HDAC4 WDR33 HNRNPM BCL9 ARID1B KMT2D TLE3 PSPC1	3.49e-06	457	144	11	32344865
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SYNRG NCOA6 RTL6 KMT2B OFD1 TRIO LAMB3 AMBRA1 PFAS TBC1D25 BCL9 CDC42BPB C2CD2L TYK2 KMT2D SGSM2 SNX8	3.55e-06	1105	144	17	35748872
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	NCOA3 DSG1 HNRNPM AMBRA1 RUVBL2 KHSRP EEF2 BBX GTF3C2 PRPF19 CHD6 HSD17B4 PSPC1	3.68e-06	655	144	13	35819319
Pubmed	Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9.	BCL9L BCL9 TLE3	3.83e-06	8	144	3	28296634
Pubmed	Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress.	HNRNPM RUVBL2 KHSRP PBRM1 PRPF19 HSD17B4 PSPC1	4.75e-06	159	144	7	22751105
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	NCOA6 GIT2 CDC42BPB C2CD2L ZNF462 NLN SETBP1 CHD6	4.79e-06	225	144	8	12168954
Pubmed	Genome-wide association analysis identifies 13 new risk loci for schizophrenia.	TCF4 ZEB2 NSUN6 PBRM1 NCAN SNX8	6.47e-06	109	144	6	23974872
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	PCED1A HDAC4 DSG1 WDR33 PAK5 HNRNPM PFAS GIT2 RAB11FIP1 RUVBL2 CDC42BPB KHSRP KPTN STK16 RNF123 TLE3 PRPF19 AFDN	6.49e-06	1284	144	18	17353931
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	TRIO DSG1 PCLO HNRNPM PFAS DBN1 THOC3 RUVBL2 ST13 KHSRP EEF2 PBRM1 GTF3C2 ENAH PRPF19 AFDN HSD17B4 MED23 PSPC1	7.19e-06	1425	144	19	30948266
Pubmed	FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands.	KMT2B ENAH ZFHX3	8.17e-06	10	144	3	9171351
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	KIF13B CACNA1E AMER1 WDR33 PCLO ITSN1 HNRNPM DBN1 ZEB2 KHSRP ACSL4 EEF2 BBX ITSN2 PRPF19 CHD6 HSD17B4 PSPC1 DNAH8	8.50e-06	1442	144	19	35575683
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	NCOA3 AMPD2 HNRNPM RAB11FIP1 KHSRP EEF2 PBRM1 GTF3C2 TLE3 ENAH AFDN	8.63e-06	503	144	11	16964243
Pubmed	Maintenance of silent chromatin through replication requires SWI/SNF-like chromatin remodeler SMARCAD1.	WDR33 HNRNPM RUVBL2 PBRM1 GTF3C2 PRPF19	9.26e-06	116	144	6	21549307
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	SYNRG TRIO HNRNPM RUVBL2 KHSRP ZNF462 EEF2 SETBP1 PRPF19 DSG4 PGM2	1.04e-05	513	144	11	25798074
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	NSUN4 WDR33 HNRNPM DBN1 THOC3 RUVBL2 KHSRP ZNF462 EEF2 ARID1B BBX PRPF19 CHD6 HSD17B4 MED23 PSPC1	1.14e-05	1082	144	16	38697112
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MIA3 AMER1 HDAC4 TRIO FRMPD1 ARHGEF18 CASC2 CDC42BPB TYK2 ZNF462 SLC35A4 SGSM2 TLE3 SETBP1 ENAH TOX3 ZFHX3 CHD6 VAV2	1.33e-05	1489	144	19	28611215
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TCF4 NSUN4 HIPK1 FRMPD1 ZEB2 MEIS1 KHSRP ACSL4 FBXW8 KMT2D BBX GTF3C2 TLE3 FOXF1	1.40e-05	857	144	14	25609649
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NCOA3 NCOA6 KMT2B HDAC4 BCL9 RUVBL2 ZEB2 KHSRP EEF2 ARID1B KMT2D TLE3 PRPF19 HSD17B4 MED23 PSPC1	1.45e-05	1103	144	16	34189442
Pubmed	Intersectin deficiency impairs cortico-striatal neurotransmission and causes obsessive-compulsive behaviors in mice.	ITSN1 ITSN2	1.70e-05	2	144	2	37603735
Pubmed	Phosphorylated cortactin recruits Vav2 guanine nucleotide exchange factor to activate Rac3 and promote invadopodial function in invasive breast cancer cells.	NCOA3 VAV2	1.70e-05	2	144	2	28356423
Pubmed	KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis.	KMT2D TP63	1.70e-05	2	144	2	29440247
Pubmed	Modulation of transporter activity of OATP1B1 and OATP1B3 by the major active components of Radix Ophiopogonis.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	29944058
Pubmed	SLCO1B1 and SLCO1B3 genetic mutations in Taiwanese patients with Rotor syndrome.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	36964102
Pubmed	Exon Inclusion Modulates Conformational Plasticity and Autoinhibition of the Intersectin 1 SH3A Domain.	ITSN1 ITSN2	1.70e-05	2	144	2	31031201
Pubmed	Intersectin associates with synapsin and regulates its nanoscale localization and function.	ITSN1 ITSN2	1.70e-05	2	144	2	29078407
Pubmed	Meis2 as a critical player in MN1-induced leukemia.	MEIS2 MN1	1.70e-05	2	144	2	28960191
Pubmed	Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	23340295
Pubmed	Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4).	KMT2B KMT2D	1.70e-05	2	144	2	35640156
Pubmed	Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	29777022
Pubmed	Down-regulation of OATP1B proteins correlates with hyperbilirubinemia in advanced cholestasis.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	26191226
Pubmed	Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions.	BCL9L BCL9	1.70e-05	2	144	2	15371335
Pubmed	The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection.	TBX21 ZEB2	1.70e-05	2	144	2	26503446
Pubmed	Utility of Oatp1a/1b-knockout and OATP1B1/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	24194513
Pubmed	Clinical significance of LAMB3 and COL7A1 mRNA in esophageal squamous cell carcinoma.	COL7A1 LAMB3	1.70e-05	2	144	2	18331784
Pubmed	Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	24855184
Pubmed	Vertebrate intersectin1 is repurposed to facilitate cortical midline connectivity and higher order cognition.	ITSN1 ITSN2	1.70e-05	2	144	2	23447614
Pubmed	Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	26474710
Pubmed	Effects of anthocyans on the expression of organic anion transporting polypeptides (SLCOs/OATPs) in primary human hepatocytes.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	25578040
Pubmed	Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	24989890
Pubmed	The human intersectin genes and their spliced variants are differentially expressed.	ITSN1 ITSN2	1.70e-05	2	144	2	11690630
Pubmed	Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	21719246
Pubmed	Organic anion transporting polypeptide 1B1 (OATP1B1) and OATP1B3: genetic variability and haplotype analysis in white Canadians.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	20877131
Pubmed	TANGO1 recruits ERGIC membranes to the endoplasmic reticulum for procollagen export.	COL7A1 MIA3	1.70e-05	2	144	2	26568311
Pubmed	BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer.	BCL9L BCL9	1.70e-05	2	144	2	33767438
Pubmed	MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease.	MEIS1 MEIS2	1.70e-05	2	144	2	29716922
Pubmed	Transport of fluorescent chenodeoxycholic acid via the human organic anion transporters OATP1B1 and OATP1B3.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	16534140
Pubmed	Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	18321482
Pubmed	St13 protects against disordered acinar cell arachidonic acid pathway in chronic pancreatitis.	ST13 ST13P5	1.70e-05	2	144	2	35562743
Pubmed	Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	18314419
Pubmed	OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	21691816
Pubmed	Myeloid ecotropic viral integration site 1 (MEIS) 1 involvement in embryonic implantation.	MEIS1 MEIS2	1.70e-05	2	144	2	18408019
Pubmed	Linking organic anion transporting polypeptide 1B1 and 1B3 (OATP1B1 and OATP1B3) interaction profiles to hepatotoxicity - The hyperbilirubinemia use case.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	28063966
Pubmed	Targeted Resequencing of 29 Candidate Genes and Mouse Expression Studies Implicate ZIC3 and FOXF1 in Human VATER/VACTERL Association.	ZIC3 FOXF1	1.70e-05	2	144	2	26294094
Pubmed	Control of mouse limb initiation and antero-posterior patterning by Meis transcription factors.	MEIS1 MEIS2	1.70e-05	2	144	2	34035267
Pubmed	Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	22240838
Pubmed	Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	17412826
Pubmed	Genetic analysis of epidermolysis bullosa: identification of mutations in LAMB3 and COL7A1 genes in three families.	COL7A1 LAMB3	1.70e-05	2	144	2	23769655
Pubmed	Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration.	BCL9L BCL9	1.70e-05	2	144	2	38811552
Pubmed	Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	22771883
Pubmed	Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	18180273
Pubmed	Adaptor proteins intersectin 1 and 2 bind similar proline-rich ligands but are differentially recognized by SH2 domain-containing proteins.	ITSN1 ITSN2	1.70e-05	2	144	2	23936226
Pubmed	Structure of human drug transporters OATP1B1 and OATP1B3.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	37723174
Pubmed	Comparison of methylation episignatures in KMT2B- and KMT2D-related human disorders.	KMT2B KMT2D	1.70e-05	2	144	2	35506254
Pubmed	Effects of Rifampin, a potent inducer of drug-metabolizing enzymes and an inhibitor of OATP1B1/3 transport, on the single dose pharmacokinetics of anacetrapib.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	23670789
Pubmed	Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes.	COL7A1 SLCO1B3	1.70e-05	2	144	2	24357722
Pubmed	Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	17496208
Pubmed	Rotor Syndrome	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	23236639
Pubmed	Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas.	BCL9L BCL9	1.70e-05	2	144	2	20682801
Pubmed	Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer.	NCOA3 NCOA6	1.70e-05	2	144	2	8758910
Pubmed	Expression Patterns of Organic Anion Transporting Polypeptides 1B1 and 1B3 Protein in Human Pediatric Liver.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	27098745
Pubmed	Introduction of aromatic ring-containing substituents in cyclic nucleotides is associated with inhibition of toxin uptake by the hepatocyte transporters OATP 1B1 and 1B3.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	24740327
Pubmed	UGT-dependent regioselective glucuronidation of ursodeoxycholic acid and obeticholic acid and selective transport of the consequent acyl glucuronides by OATP1B1 and 1B3.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	31299240
Pubmed	In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	23886114
Pubmed	OATP1B1/1B3 activity in plated primary human hepatocytes over time in culture.	SLCO1B3 SLCO1B1	1.70e-05	2	144	2	21787759
Pubmed	Mutation of ARHGAP9 in patients with coronary spastic angina.	TRIO OPHN1 ITSN2 VAV2	1.86e-05	38	144	4	19911011
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	NCOA3 NCOA6 ARID1B KMT2D TLE3	1.88e-05	78	144	5	28611094
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCOA3 SYNRG NCOA6 KMT2B ITSN1 DBN1 BCL9 EEF2 KMT2D TLE3 TRAPPC10 AFDN MN1	2.16e-05	774	144	13	15302935
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	TRIO DSG1 WDR33 ITSN1 MRPL10 ARHGEF18 GIT2 ST13 OPHN1 ITSN2 ENAH HSD17B4 PSPC1 VAV2	2.91e-05	916	144	14	32203420
Pubmed	H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.	NCOA6 KMT2B KMT2D	3.74e-05	16	144	3	24368734
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	NCOA3 AMPD2 PCLO ZEB2 TYK2 ARID1B KMT2D PBRM1 TLE3	4.50e-05	398	144	9	35016035
Pubmed	MLL3 and MLL4 Methyltransferases Bind to the MAFA and MAFB Transcription Factors to Regulate Islet β-Cell Function.	NCOA6 KMT2B KMT2D	4.53e-05	17	144	3	26180087
Pubmed	Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions.	SLCO1B3 SLCO1B1	5.09e-05	3	144	2	31047942
Pubmed	Multiple Genetic Modifiers of Bilirubin Metabolism Involvement in Significant Neonatal Hyperbilirubinemia in Patients of Chinese Descent.	SLCO1B3 SLCO1B1	5.09e-05	3	144	2	26146841
Interaction	GSC interactions	BCL9L NCOA3 TBX21 BCL9 ZEB2 ZNF462 ARID1B KMT2D TLE3 ZFHX3 DSG4	2.55e-11	87	142	11	int:GSC
Interaction	FEV interactions	NCOA3 NCOA6 KMT2B BCL9 ZEB2 ZNF462 ARID1B KMT2D PBRM1 GTF3C2 TLE3 ZFHX3 CHD6	2.08e-09	203	142	13	int:FEV
Interaction	PAX9 interactions	BCL9L NCOA3 NCOA6 TBX21 BCL9 ARID1B KMT2D PBRM1 TLE3 ZFHX3	2.84e-08	130	142	10	int:PAX9
Interaction	EGR2 interactions	BCL9L NCOA3 NCOA6 HDAC4 BCL9 ZEB2 ZNF462 ARID1B KMT2D TLE3 ZFHX3	3.63e-08	171	142	11	int:EGR2
Interaction	TLX1 interactions	NCOA3 BCL9 ZEB2 MEIS1 MEIS2 ZNF462 ARID1B KMT2D PBRM1 TLE3 ZFHX3	4.60e-08	175	142	11	int:TLX1
Interaction	TLX3 interactions	BCL9L NCOA3 NCOA6 TBX21 DBN1 BCL9 MEIS1 ARID1B KMT2D PBRM1 TLE3 ZFHX3 CHD6	1.50e-07	291	142	13	int:TLX3
Interaction	GATA2 interactions	NCOA3 NCOA6 BCL9 ZEB2 ARID1B KMT2D PBRM1 TLE3 TRAPPC10 ZFHX3 CHD6	1.71e-07	199	142	11	int:GATA2
Interaction	AR interactions	BCL9L NCOA3 TCF4 NCOA6 HDAC4 WDR33 HNRNPM RAB11FIP1 BCL9 RUVBL2 KHSRP ZNF462 EEF2 ARID1B KMT2D MLH3 PBRM1 TLE3 PRPF19 ZFHX3 MED23 PSPC1 VAV2	4.49e-07	992	142	23	int:AR
Interaction	HNF4A interactions	NCOA3 NCOA6 KMT2B HDAC4 ZEB2 STK16 ZNF462 ARID1B KMT2D PBRM1 GTF3C2 MED23	5.92e-07	275	142	12	int:HNF4A
Interaction	TLX2 interactions	DBN1 BCL9 MEIS1 ARID1B KMT2D PBRM1 TLE3 ZFHX3 CHD6	7.49e-07	142	142	9	int:TLX2
Interaction	TBR1 interactions	BCL9L NCOA3 BCL9 RNF123 ARID1B KMT2D TLE3 ZFHX3	1.37e-06	113	142	8	int:TBR1
Interaction	SP7 interactions	BCL9L NCOA3 NCOA6 KMT2B WDR33 BCL9 ZEB2 RNF123 ARID1B KMT2D PBRM1 TLE3	1.70e-06	304	142	12	int:SP7
Interaction	CRX interactions	BCL9L NCOA3 BCL9 ZEB2 STK16 ZNF462 ARID1B KMT2D PBRM1 TLE3 ZFHX3	1.91e-06	254	142	11	int:CRX
Interaction	PAX6 interactions	NCOA3 NCOA6 BCL9 ZEB2 MEIS2 ZNF462 ARID1B KMT2D PBRM1 GTF3C2 TLE3 ZFHX3 CHD6	2.00e-06	366	142	13	int:PAX6
Interaction	SOX9 interactions	NCOA3 NCOA6 BCL9 ARID1B KMT2D PBRM1 TLE3	5.63e-06	97	142	7	int:SOX9
Interaction	HNF1B interactions	NCOA3 BCL9 RUVBL2 ZEB2 ARID1B KMT2D PBRM1 TLE3 ZFHX3	8.27e-06	190	142	9	int:HNF1B
Interaction	GCM1 interactions	NCOA3 HDAC4 BCL9 ARID1B KMT2D TLE3	8.41e-06	68	142	6	int:GCM1
Interaction	MYOD1 interactions	NCOA3 TCF4 BCL9 ZEB2 ARID1B KMT2D PBRM1 TLE3 EXOC3L1	9.79e-06	194	142	9	int:MYOD1
Interaction	PAX8 interactions	NCOA3 BCL9 ZEB2 ARID1B KMT2D PBRM1 TLE3	1.37e-05	111	142	7	int:PAX8
Interaction	TBXT interactions	NCOA3 NCOA6 BCL9 ZEB2 ARID1B KMT2D TLE3	1.83e-05	116	142	7	int:TBXT
Interaction	SCARNA22 interactions	HNRNPM RUVBL2 KHSRP PBRM1 PRPF19 HSD17B4 PSPC1	2.04e-05	118	142	7	int:SCARNA22
Interaction	ETS1 interactions	NCOA3 MEIS1 ARID1B KMT2D PBRM1 TLE3 MED23	2.40e-05	121	142	7	int:ETS1
Interaction	SOX7 interactions	NCOA3 ZEB2 ARID1B KMT2D PBRM1 TLE3	2.48e-05	82	142	6	int:SOX7
Interaction	PAX7 interactions	NCOA3 BCL9 ARID1B KMT2D TLE3 ZFHX3 CHD6	2.82e-05	124	142	7	int:PAX7
Interaction	ERG interactions	NCOA3 NCOA6 HIPK1 HNRNPM DBN1 BCL9 ARID1B KMT2D TLE3	2.96e-05	223	142	9	int:ERG
Interaction	TEAD1 interactions	ZEB2 ZNF462 ARID1B KMT2D PBRM1 TLE3 TP63 ZFHX3	3.58e-05	176	142	8	int:TEAD1
Interaction	NUP35 interactions	BCL9L NCOA3 NCOA6 HDAC4 WDR33 HNRNPM BCL9 ARID1B KMT2D TLE3 AFDN PSPC1	4.77e-05	424	142	12	int:NUP35
Interaction	SOX10 interactions	NCOA3 TCF4 BCL9 ARID1B KMT2D PBRM1	4.77e-05	92	142	6	int:SOX10
Interaction	KIF20A interactions	WDR33 S100A7L2 PCLO CD109 HNRNPM AMBRA1 DBN1 RUVBL2 CDC42BPB ZEB2 KHSRP ITPR1 ZNF462 ACSL4 NLN EEF2 PRPF19 HSD17B4 MGAT5B PGM2	4.92e-05	1052	142	20	int:KIF20A
Interaction	GATA3 interactions	NCOA3 HDAC4 TBX21 BCL9 ARID1B KMT2D PBRM1 TLE3	5.50e-05	187	142	8	int:GATA3
Interaction	SOX17 interactions	NCOA3 NCOA6 BCL9 ARID1B KMT2D PBRM1	5.72e-05	95	142	6	int:SOX17
Interaction	PPARG interactions	NCOA3 TCF4 NCOA6 HDAC4 HNRNPM RUVBL2 KHSRP ARID1B KMT2D PBRM1	6.57e-05	307	142	10	int:PPARG
Interaction	KLF5 interactions	NCOA3 NCOA6 BCL9 ARID1B KMT2D PBRM1 TLE3 TP63	7.39e-05	195	142	8	int:KLF5
Interaction	FOS interactions	NCOA3 NCOA6 DBN1 BCL9 KHSRP ARID1B KMT2D PBRM1 DSG4 HSD17B4	7.51e-05	312	142	10	int:FOS
Interaction	FAM222A interactions	MEIS1 MEIS2 FBXW8	9.30e-05	13	142	3	int:FAM222A
Interaction	ETV4 interactions	NCOA3 BCL9 ARID1B KMT2D TP63	1.27e-04	69	142	5	int:ETV4
Interaction	SYDE1 interactions	KIF13B HDAC4 DSG1 WDR33 TBC1D25 AFDN	1.29e-04	110	142	6	int:SYDE1
Interaction	CHD6 interactions	TCF4 HDAC4 RNF123 TLE3 CHD6	1.45e-04	71	142	5	int:CHD6
Interaction	C16orf90 interactions	RNF123 TP63	1.47e-04	3	142	2	int:C16orf90
Interaction	SOX2 interactions	BCL9L NCOA3 ATP6V1B1 NCOA6 INTS7 HNRNPM DBN1 BCL9 RUVBL2 ZEB2 MEIS2 KHSRP ZNF462 EEF2 ARID1B KMT2D PBRM1 TLE3 TP63 PRPF19 ZFHX3 CHD6 PGM2	1.51e-04	1422	142	23	int:SOX2
Interaction	SETD1B interactions	NCOA6 KMT2B HDAC4 KMT2D TP63	1.88e-04	75	142	5	int:SETD1B
Interaction	WWTR1 interactions	SYNRG NCOA6 DBN1 RUVBL2 KHSRP ARID1B KMT2D GTF3C2 TP63 ENAH AFDN	2.04e-04	422	142	11	int:WWTR1
Interaction	TWIST1 interactions	TCF4 ST13 ZEB2 ZIC3 PBRM1 BBX CHD6	2.06e-04	170	142	7	int:TWIST1
Interaction	NFIX interactions	KMT2B ZEB2 ARID1B KMT2D PBRM1 GTF3C2 TLE3 ZFHX3	2.11e-04	227	142	8	int:NFIX
Interaction	KLF3 interactions	KMT2B ZEB2 ARID1B KMT2D PBRM1 TLE3 ZFHX3 CHD6	2.17e-04	228	142	8	int:KLF3
Interaction	AMER3 interactions	AMER1 RNF123	2.93e-04	4	142	2	int:AMER3
Interaction	ALG13 interactions	NCOA3 MIA3 WDR33 BCL9 ARID1B KMT2D TLE3	3.22e-04	183	142	7	int:ALG13
Interaction	LHX2 interactions	BCL9L BCL9 ZEB2 ARID1B KMT2D PBRM1 ZFHX3	3.22e-04	183	142	7	int:LHX2
Interaction	SMAD3 interactions	NCOA3 NCOA6 KMT2B HDAC4 GIT2 ZEB2 ARID1B ZFHX3 PSPC1 VAV2 CCDC33	3.33e-04	447	142	11	int:SMAD3
Interaction	MEN1 interactions	KIF13B NCOA6 KMT2B WDR33 HNRNPM RUVBL2 KHSRP ZNF462 ARID1B KMT2D PBRM1 GTF3C2 TLE3 SETBP1 PRPF19 AFDN HSD17B4 PSPC1	3.36e-04	1029	142	18	int:MEN1
Interaction	IRF4 interactions	NCOA3 OFD1 ARID1B KMT2D PBRM1	3.38e-04	85	142	5	int:IRF4
Interaction	PAX2 interactions	NCOA3 BCL9 ARID1B KMT2D TLE3	3.38e-04	85	142	5	int:PAX2
Interaction	FBXW7 interactions	NCOA3 NCOA6 NSUN4 HNRNPM LAMB3 GIT2 RUVBL2 CDC42BPB ZEB2 KCTD17 EEF2 KMT2D GTF3C2 TP63 SNX8 PRPF19 CHD6 KCTD2 MED23 PSPC1	3.40e-04	1215	142	20	int:FBXW7
Interaction	TLE3 interactions	BCL9L NCOA3 TCF4 BCL9 ARID1B KMT2D TLE3 ZFHX3 CHD6 MED23	3.40e-04	376	142	10	int:TLE3
Interaction	KDM1A interactions	NCOA3 ATP6V1B1 TCF4 KMT2B OFD1 RUVBL2 ZEB2 ZNF462 KMT2D GTF3C2 TLE3 ITSN2 ZFHX3 CHD6 MED23 PSPC1 CCDC33	3.43e-04	941	142	17	int:KDM1A
Interaction	PYGO2 interactions	BCL9L BCL9 KMT2D TLE3	3.61e-04	48	142	4	int:PYGO2
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PCLO ITSN1 RAB11FIP1 ITSN2 CCDC33	1.32e-06	36	97	5	823
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO ITSN1 ARHGEF18 ITSN2 VAV2	2.76e-05	66	97	5	722
GeneFamily	WD repeat domain containing	WDR33 WDR81 AMBRA1 THOC3 FBXW8 GTF3C2 TLE3 PRPF19	8.30e-05	262	97	8	362
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOA3 KMT2D TOX3	3.16e-04	25	97	3	775
GeneFamily	NOP2/Sun RNA methyltransferase family	NSUN4 NSUN6	5.88e-04	7	97	2	664
GeneFamily	Desmosomal cadherins	DSG1 DSG4	5.88e-04	7	97	2	1188
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZEB2 ZFHX3	2.86e-03	15	97	2	529
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	POMT2 TRIO LAMB3 GIT2 ZEB2 MEIS1 MEIS2 ITPR1 NSUN6 TLE3 SETBP1 ITSN2 ENAH TOX3 EID1 CHD6 KCTD2 MN1 FOXF1	2.59e-06	1009	143	19	M157
ToppCell	IPF-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	NCOA3 TCF4 TRIO ARHGEF18 ITPR1 SETBP1 SNX8 VAV2	1.60e-07	187	142	8	af1327559f7e01bec070881cae52834917c3da65
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KIF13B SYNRG OFD1 TBX21 APBA2 DBN1 ZEB2 TRAPPC10	2.20e-07	195	142	8	0a72b8446399807ace5b6c72f865bb40dbd9e92d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRMPD1 NRG2 XKR6 OPHN1 ITPR1 ACSL4 TOX3	1.91e-06	181	142	7	e0abf2707d9e0aa942c657eef7d2cbcd02f060dd
ToppCell	Control-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	NCOA3 TCF4 TRIO ARHGEF18 SETBP1 SNX8 VAV2	2.37e-06	187	142	7	4e64be635f445276e71f2937f33f041c3a4204ab
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCOA3 TCF4 TRIO RAB11FIP1 ITPR1 SNX8 VAV2	2.64e-06	190	142	7	60bb6aaea9691d07295f61c14d1650f5041a0f9c
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	NCOA3 TCF4 TRIO RAB11FIP1 SETBP1 SNX8 VAV2	2.64e-06	190	142	7	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	TCF4 LAMB3 ARID1B ENAH TOX3 AFDN ZFHX3	2.64e-06	190	142	7	842760bfe0a52e67bad800efa7d99448a4a23ebb
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCF4 TRIO RAB11FIP1 ITPR1 SETBP1 ITSN2 VAV2	2.92e-06	193	142	7	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCF4 CD109 SLCO1B3 MEIS2 TOX3 EXOC3L1 AFDN	2.92e-06	193	142	7	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCF4 CD109 SLCO1B3 MEIS2 TOX3 EXOC3L1 AFDN	3.02e-06	194	142	7	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCF4 CD109 SLCO1B3 MEIS2 TOX3 EXOC3L1 AFDN	3.02e-06	194	142	7	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCF4 CD109 SLCO1B3 MEIS2 TOX3 EXOC3L1 AFDN	3.02e-06	194	142	7	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCF4 CD109 SLCO1B3 MEIS2 TOX3 EXOC3L1 AFDN	3.02e-06	194	142	7	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	IPF-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	CD109 ZEB2 MEIS1 OPHN1 ABHD17C MN1 FOXF1	3.24e-06	196	142	7	8f0f72ead06abe02b575e443552eacc2151077ef
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-basal_cell_of_epidermis\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL7A1 LAMB3 MEIS1 MEIS2 EEF2 TP63 EID1	3.24e-06	196	142	7	d4df86ce289835e76763213641989fde77935a16
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	TCF4 ZEB2 MEIS2 ZNF462 ENAH ZNF91 MN1	3.46e-06	198	142	7	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	CACNA1E PCLO PAK5 ZEB2 OPHN1 NLN MN1	3.70e-06	200	142	7	84e4565d28a02700bf7f6730d1b3a58744ca0aea
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	CACNA1E TCF4 PCLO PAK5 ZEB2 AFDN ZNF91	3.70e-06	200	142	7	bad32a95b759fad509401b07bc96a56687c2a592
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KIF13B TBX21 PBRM1 MOB1B AGXT DNAH8	5.89e-06	140	142	6	af9efcbaeeae69fcdac4a15fa244728b65915564
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCF4 TRIO RAB11FIP1 ZEB2 ITPR1 SETBP1	1.40e-05	163	142	6	6bed27d2f67a430a847da5eb47878d14b4949c45
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	MIA3 HIPK1 RNF123 ARID1B BBX AFDN	1.56e-05	166	142	6	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	Bronchial_Biopsy-Immune-Mast_cells\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	GPRASP1 HDAC4 NRG2 XKR6 MEIS2 ZNF462	1.67e-05	168	142	6	45ccc0cb42d21f4853190e8e9ed9a54aefefe738
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TCF4 TRIO CD109 LAMB3 SNX8 AFDN	1.78e-05	170	142	6	cc66ac6846c58be9493eb270644ee3ce0f86cfea
ToppCell	facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E TCF4 ITSN1 NRG2 ITPR1 SEC24D	2.17e-05	176	142	6	74f851a398c7562dd713bc0d8d488c0037243112
ToppCell	normal_Lymph_Node-Myeloid_cells-pDCs\|normal_Lymph_Node / Location, Cell class and cell subclass	TCF4 PFAS RAB11FIP1 ZEB2 OPHN1 SETBP1	2.17e-05	176	142	6	476794ef75ce5ab732d78cfeb4944e2f841e3e92
ToppCell	facs-Marrow-T_cells-18m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E TCF4 ITSN1 NRG2 ITPR1 SEC24D	2.17e-05	176	142	6	31b5459a978d5cdde0af03a77401e0464d8c95ba
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 CD109 MEIS2 EXOC3L1 MN1 MGAT5B	2.17e-05	176	142	6	dc5a22f9d1347f157bdd93e6e5769b983deccf1a
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCF4 MEIS1 ITPR1 FRRS1 SNX8 DNAH8	2.87e-05	185	142	6	3563dd39ec58d3273f95f5bb36b9ccdc0aafb63a
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231\|Adult / Lineage, Cell type, age group and donor	TCF4 CD109 MEIS1 MEIS2 MGAT5B FOXF1	2.87e-05	185	142	6	07f9f38f0739d7c830641723a38385550ac1ac92
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	XKR6 OPHN1 ITPR1 ACSL4 TOX3 SLC16A7	3.14e-05	188	142	6	bc089cd73d283ed7d2ecbb3936673b4edc89f666
ToppCell	368C-Epithelial_cells-Epithelial-I_(AT1)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	LAMB3 AMBRA1 ABHD17C KCTD2 MED23 SLC23A3	3.14e-05	188	142	6	c74771584b3ba9561a99a54bf55a9203ddf8eff8
ToppCell	COPD-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	NCOA3 XKR6 MEIS1 OPHN1 ZFHX3 FOXF1	3.14e-05	188	142	6	1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	XKR6 OPHN1 ITPR1 ACSL4 TOX3 SLC16A7	3.14e-05	188	142	6	eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCell	368C-Epithelial_cells-Epithelial-I_(AT1)\|368C / Donor, Lineage, Cell class and subclass (all cells)	LAMB3 AMBRA1 ABHD17C KCTD2 MED23 SLC23A3	3.14e-05	188	142	6	9155b9a92496e75646778c025b02947e9e9ec73a
ToppCell	CTRL-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	NCOA3 TCF4 TRIO SETBP1 SNX8 VAV2	3.23e-05	189	142	6	14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e
ToppCell	IPF-Epithelial-Basal\|Epithelial / Disease state, Lineage and Cell class	COL7A1 CD109 LAMB3 THOC3 ACSL4 TP63	3.33e-05	190	142	6	4f15842b424eefadbfe451875e517cf70e29607f
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|lymph-node_spleen / Manually curated celltypes from each tissue	KIF13B TBX21 APBA2 MRPL10 DBN1 ZEB2	3.43e-05	191	142	6	f802a4686ecf00e8302047bfe23356f24b266cf8
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo\|lymph-node_spleen / Manually curated celltypes from each tissue	KIF13B TBX21 APBA2 MRPL10 DBN1 ZEB2	3.53e-05	192	142	6	4d72b9264ed62e0c08cde4078061b348253f6989
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD109 SLCO1B3 MEIS2 TOX3 EXOC3L1 AFDN	3.53e-05	192	142	6	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD109 SLCO1B3 MEIS2 TOX3 EXOC3L1 AFDN	3.53e-05	192	142	6	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD109 SLCO1B3 MEIS2 TOX3 EXOC3L1 AFDN	3.64e-05	193	142	6	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD109 SLCO1B3 MEIS2 TOX3 EXOC3L1 AFDN	3.64e-05	193	142	6	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	CF-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	NCOA3 TRIO SETBP1 SNX8 DNAH8 VAV2	3.64e-05	193	142	6	7ebf20344a9a154fd2cffa281526867fcf0aded3
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NCOA3 TCF4 ITPR1 ARID1B SETBP1 VAV2	3.74e-05	194	142	6	ff661419b697aef51a53fdeac8d37d870d65f491
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCF4 SLCO1B3 MEIS2 TOX3 EXOC3L1 AFDN	3.74e-05	194	142	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCOA3 TCF4 RAB11FIP1 ZEB2 ITPR1 SETBP1	3.85e-05	195	142	6	481989d2e5bd2582da3d86b0155c4d6615317067
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCOA3 TCF4 RAB11FIP1 ZEB2 ITPR1 SETBP1	3.85e-05	195	142	6	6108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	TCF4 DBN1 MEIS2 ZNF462 BBX SETBP1	3.96e-05	196	142	6	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	TCF4 DBN1 MEIS2 ZNF462 BBX SETBP1	3.96e-05	196	142	6	721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn\|World / Primary Cells by Cluster	TCF4 PAK5 MEIS2 ZNF462 ZNF91 MN1	3.96e-05	196	142	6	9401bd84798f0ea3e986e94135a9e1dc5643330f
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TCF4 CD109 MEIS1 MEIS2 EXOC3L1 FOXF1	4.08e-05	197	142	6	81718164c9802ee20c860ffbda7e62d5e9a76f16
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TCF4 COL7A1 NRG2 THOC3 TP63 SETBP1	4.08e-05	197	142	6	1e915957ea6a4550ecb9d6ee4b232aa5800faf20
ToppCell	COVID-19-lung-Capillary_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TCF4 CD109 MEIS1 MEIS2 EXOC3L1 FOXF1	4.19e-05	198	142	6	45419f2804b4be79bae6632e71c54e1af482d115
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TCF4 ZEB2 MEIS1 MEIS2 EID1 FOXF1	4.19e-05	198	142	6	ebceb11f50b8a6ebb7629fdbd3d31fb131ace6fd
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	TRIO AMBRA1 XKR6 MEIS1 OPHN1 ARID1B	4.31e-05	199	142	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	3'-GW_trimst-1\|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DBN1 MEIS2 EEF2 ENAH EID1 FOXF1	4.31e-05	199	142	6	ecfb6381e2971a3e355e661a6df0021914485e74
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PCLO MEIS1 MEIS2 TP63 ENAH AFDN	4.43e-05	200	142	6	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related\|10w / Sample Type, Dataset, Time_group, and Cell type.	TCF4 MEIS1 BBX SETBP1 TOX3 AFDN	4.43e-05	200	142	6	8f5d98f962ddd8c4658c89ff8a2894de1228562a
ToppCell	Influenza-Influenza_Severe-Myeloid-cDC\|Influenza_Severe / Disease, condition lineage and cell class	CD109 LYSMD4 RUVBL2 OPHN1 FRRS1 CTPS2	4.43e-05	200	142	6	b8415a68ad6f4fea562236a1b0da0dc376d874fb
ToppCell	mild-B_intermediate\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NCOA3 TCF4 ARID1B SETBP1 ITSN2 DNAH8	4.43e-05	200	142	6	fe815824e9e4be3f3db73610e3814a7fd533da65
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	CACNA1E PCLO ZEB2 MEIS2 OPHN1 MN1	4.43e-05	200	142	6	19055194a5e0ea122f1b8fc62df44813f6843c95
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	CACNA1E TCF4 PAK5 ZEB2 ZNF91 MN1	4.43e-05	200	142	6	306926cb7a847871641f02e03d52dc56fd55711c
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related-Oligodendrocyte/OPC\|10w / Sample Type, Dataset, Time_group, and Cell type.	TCF4 MEIS1 BBX SETBP1 TOX3 AFDN	4.43e-05	200	142	6	345f1eac498cc87fd7bf08e7312608b2d6fe1dd7
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PCLO MEIS1 MEIS2 TP63 ENAH AFDN	4.43e-05	200	142	6	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-9\|TCGA-Kidney / Sample_Type by Project: Shred V9	FRMPD1 ZIC3 TOMM40L AGRP ZNF98	6.54e-05	132	142	5	f1ef63a4842ab6ca584a9dcc2dd5b2108fc990aa
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	FREM3 BARHL2 RTL9 EXOC3L1 ONECUT3	1.35e-04	154	142	5	df1b58a20af73fa79c6c069c0117a9ffd85b476f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BCL9L TCF4 CD109 MEIS2 MN1	1.35e-04	154	142	5	e51a5114f0ec38f997f5b8bbf3a7770f98595474
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NRG2 XKR6 OPHN1 ITPR1 TOX3	1.52e-04	158	142	5	7960337d87afecf2692ab65e5991f052ceddfacc
ToppCell	COVID-CD4-CD4_Treg\|COVID / Condition, Cell_class and T cell subcluster	KIF13B AMPD2 BCL9 KCTD17 KMT2D	1.57e-04	159	142	5	037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRMPD1 OPHN1 ITPR1 ACSL4 TOX3	1.62e-04	160	142	5	8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRMPD1 OPHN1 ITPR1 ACSL4 TOX3	1.62e-04	160	142	5	2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCF4 TRIO FBXW8 SNX8 VAV2	1.66e-04	161	142	5	63f0b97c741b610c450f65fa5764d712bfe09ce8
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|356C / Donor, Lineage, Cell class and subclass (all cells)	NRG2 KPTN FRRS1 EXOC3L1 SPOCD1	1.71e-04	162	142	5	7d43d59531cbefe3ac94953b7faf7156b2a31441
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma\|TCGA-Cervix / Sample_Type by Project: Shred V9	COL7A1 CD109 LAMB3 HSF5 TP63	1.81e-04	164	142	5	de1646dbcf2a10b48e021acf7dc63e803e6a47ce
ToppCell	Control-NK\|Control / Disease group and Cell class	TCF4 CD109 MEIS1 ZFHX3 VAV2	2.03e-04	168	142	5	683d389c8a1e791bfc773e63148115a21a6566db
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL7A1 NRG2 LAMB3 DBN1 TP63	2.14e-04	170	142	5	0cc20322cb3e3e7bbd4daad8785c99f80e355c16
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PCED1A TBX21 KCTD17 SETBP1 PRPF19	2.14e-04	170	142	5	32917888c3f1d54302675c1d4de1fd3b7c79af5f
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL7A1 NRG2 LAMB3 DBN1 TP63	2.14e-04	170	142	5	2d880223d01bde4bf777bd6f50b7d2768489075f
ToppCell	AT1-AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	ASCL5 LAMB3 SLCO1B3 DBN1 ZFHX3	2.26e-04	172	142	5	0be41df5d35d818deb7316ac21c9366eb4b7bfd1
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCF4 TRIO RAB11FIP1 ZEB2 ITPR1	2.32e-04	173	142	5	d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRMPD1 NRG2 OPHN1 ACSL4 TOX3	2.32e-04	173	142	5	4bc6d93716f093b460c8b047199db8cab5fea720
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-E\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	CD109 MEIS1 MEIS2 SETBP1 FOXF1	2.39e-04	174	142	5	4a1b67ce5ea353b3f81f59fa57da07668146afca
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCOA3 KMT2B RAB11FIP1 SETBP1 ITSN2	2.39e-04	174	142	5	ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e
ToppCell	Nasal_Brush-Epithelial-Basal_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	COL7A1 PAK5 LAMB3 TP63 SPOCD1	2.52e-04	176	142	5	fc5787946f5a10056d326d070620575ae4081836
ToppCell	Nasal_Brush-Epithelial-Basal_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	COL7A1 PAK5 LAMB3 TP63 SPOCD1	2.52e-04	176	142	5	5daaba0853afe7d20d4635169ccd4f96e735b938
ToppCell	COVID-19-lung-B_cells\|lung / Disease (COVID-19 only), tissue and cell type	NCOA3 XKR6 ITPR1 SETBP1 DNAH8	2.58e-04	177	142	5	f54691e5558091c1734ab15153a10bff15ed171e
ToppCell	Control-Myeloid-pDC\|Control / Disease state, Lineage and Cell class	TCF4 OFD1 PFAS MOB1B SETBP1	2.58e-04	177	142	5	3940663bb5b45b2ca9f772550380a516c53e410b
ToppCell	COVID-19-B_cells-Activated_B_cells\|COVID-19 / group, cell type (main and fine annotations)	NCOA3 XKR6 ITPR1 SETBP1 DNAH8	2.58e-04	177	142	5	653bb62a3744d4024ab3186ee01d410ed62832a6
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	KIF13B NCOA3 MEIS2 HSF5 MLH3	2.58e-04	177	142	5	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL7A1 LAMB3 WFIKKN1 TP63 ZNF98	2.58e-04	177	142	5	75cb2067a3f2d1b5a964890b02b604d1e79bd163
ToppCell	Control-Myeloid-pDC\|Myeloid / Disease state, Lineage and Cell class	TCF4 OFD1 PFAS MOB1B SETBP1	2.58e-04	177	142	5	e82115bfc32c7b689460fbc5caeb983c1aabe30f
ToppCell	Control-Myeloid-pDC\|World / Disease state, Lineage and Cell class	TCF4 OFD1 PFAS MOB1B SETBP1	2.65e-04	178	142	5	20ef63d925e67ddd5955832312ca8574a6f838a4
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCED1A KIF13B PCLO SEC24D ENAH	2.65e-04	178	142	5	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	COVID-19-kidney-vSMC/Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MEIS1 MEIS2 SETBP1 ZFHX3 PGM2	2.72e-04	179	142	5	111b1084f73306bdeffaaf240e7dbb4f5bf33de1
ToppCell	COPD-Myeloid-pDC\|Myeloid / Disease state, Lineage and Cell class	TCF4 OFD1 PFAS MOB1B SETBP1	2.72e-04	179	142	5	29b058c5e33fda9f0d738c074bdb67ff16b9b6d5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRMPD1 OPHN1 ITPR1 ACSL4 TOX3	2.72e-04	179	142	5	666072c0e8448dbaec1683d18368ec2502453f90
ToppCell	IPF-Myeloid-pDC\|Myeloid / Disease state, Lineage and Cell class	TCF4 OFD1 PFAS MOB1B SETBP1	2.79e-04	180	142	5	0f8567aa835d4e3a52f6631ae15216eca18a030c
ToppCell	facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E TCF4 ZEB2 ITPR1 SEC24D	2.79e-04	180	142	5	bf8d13d4db1af55b8c9fe16aaccf8743e000e005
ToppCell	facs-Marrow-B-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E TCF4 ZEB2 ITPR1 SEC24D	2.79e-04	180	142	5	839defb40f7cfb2711e9025194de636533f51bcd
ToppCell	IPF-Lymphoid-B\|World / Disease state, Lineage and Cell class	NCOA3 ARHGEF18 XKR6 ITPR1 SETBP1	2.79e-04	180	142	5	30f9398c9b784f49470847a025bac90687e997a1
Computational	Genes in the cancer module 453.	GPRASP1 CD109 KMT2D ITSN2 VAV2	1.64e-05	44	79	5	MODULE_453
Computational	Genes in the cancer module 11.	GPRASP1 APBA2 NRG2 FAM131A DBN1 BCL9 MEIS2 KCTD17 ITPR1 NCAN SETBP1 TM7SF2 PRPF19	1.40e-04	540	79	13	MODULE_11
Computational	Genes in the cancer module 66.	GPRASP1 APBA2 NRG2 FAM131A DBN1 BCL9 MEIS2 KCTD17 ITPR1 NCAN SETBP1 TM7SF2 PRPF19	1.74e-04	552	79	13	MODULE_66
Computational	Genes in the cancer module 100.	GPRASP1 APBA2 NRG2 FAM131A DBN1 MEIS2 KCTD17 ITPR1 NCAN SETBP1 TM7SF2 PRPF19	5.74e-04	544	79	12	MODULE_100
Computational	CNS genes.	GPRASP1 APBA2 NRG2 FAM131A DBN1 MEIS2 KCTD17 ITPR1 NCAN SETBP1 TM7SF2 PRPF19	5.93e-04	546	79	12	MODULE_137
Drug	Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; PC3; HT_HG-U133A	TCF4 WDR33 ITSN1 AMBRA1 DBN1 C2CD2L ACSL4 TLE3 SETBP1 ZFHX3	4.84e-07	198	142	10	5793_DN
Drug	Acemetacin [53164-05-9]; Down 200; 9.6uM; PC3; HT_HG-U133A	POMT2 NCOA3 TCF4 KMT2B ITPR1 C2CD2L SEC24D SETBP1 ZFHX3 PRMT7	5.07e-07	199	142	10	6361_DN
Drug	fullerene C60	CACNA1E NCOA3 TCF4 NCOA6 COL7A1 AMPD2 TRIO INTS7 ITSN1 APBA2 NRG2 LAMB3 ARHGEF18 SLCO1B3 PFAS RAB11FIP1 LY6G5C CDC42BPB C2CD2L BBX SGSM2 SNX8 TRAPPC10 EXOC3L1 PRMT7 CCDC33	1.78e-06	1498	142	26	ctd:C069837
Drug	17-AAG; Up 200; 1uM; PC3; HG-U133A	NCOA3 TCF4 COL7A1 ITSN1 AMBRA1 ARHGEF18 GIT2 C2CD2L SEC24D	2.62e-06	186	142	9	432_UP
Drug	Furosemide [54-31-9]; Up 200; 12uM; HL60; HG-U133A	KMT2B APBA2 AMBRA1 ITPR1 ACSL4 EID1 TM7SF2 SLC16A7	2.83e-05	192	142	8	1580_UP
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A	SYNRG ITSN1 LAMB3 BCL9 MEIS1 C2CD2L TLE3 TRAPPC10	3.05e-05	194	142	8	1670_DN
Drug	Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; PC3; HT_HG-U133A	KIF13B NCOA3 TRIO HIPK1 ITSN1 RAB11FIP1 MEIS1 PRMT7	3.28e-05	196	142	8	7320_DN
Drug	DO 897/99; Down 200; 8.2uM; MCF7; HT_HG-U133A	HDAC4 GIT2 DBN1 BCL9 MEIS1 C2CD2L MLH3 TLE3	3.40e-05	197	142	8	7462_DN
Drug	Amidopyrine [58-15-1]; Down 200; 17.2uM; PC3; HT_HG-U133A	POMT2 KIF13B KMT2B PCLO BCL9 ITPR1 SGSM2 TM7SF2	3.40e-05	197	142	8	2060_DN
Drug	Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; HL60; HG-U133A	NCOA3 GIT2 ZEB2 ITPR1 ACSL4 BBX ITSN2 EID1	3.65e-05	199	142	8	1440_DN
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; HL60; HT_HG-U133A	COL7A1 NRG2 SLCO1B1 KCTD17 KMT2D SETBP1 AGXT ZFHX3	3.65e-05	199	142	8	2543_UP
Drug	(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid	SLCO1B3 SLCO1B1	3.86e-05	2	142	2	ctd:C561635
Disease	Malignant neoplasm of breast	NCOA3 NCOA6 COL7A1 HDAC4 FRMPD1 CD109 FAM131A DBN1 SLCO1B1 ZEB2 MEIS1 EEF2 ARID1B NSUN6 KMT2D PBRM1 CSF3 TLE3 SETBP1 ITSN2 TOX3 EXOC3L1 SPOCD1	9.34e-10	1074	137	23	C0006142
Disease	Breast Carcinoma	NCOA3 COL7A1 CD109 SLCO1B1 ZEB2 MEIS1 EEF2 ARID1B NSUN6 KMT2D PBRM1 CSF3 TLE3 SETBP1 ITSN2 TOX3	4.65e-09	538	137	16	C0678222
Disease	Mammary Carcinoma, Human	NCOA3 COL7A1 CD109 SLCO1B1 ZEB2 MEIS1 EEF2 NSUN6 KMT2D CSF3 TLE3 SETBP1 ITSN2 TOX3	1.72e-07	525	137	14	C4704874
Disease	Mammary Neoplasms, Human	NCOA3 COL7A1 CD109 SLCO1B1 ZEB2 MEIS1 EEF2 NSUN6 KMT2D CSF3 TLE3 SETBP1 ITSN2 TOX3	1.72e-07	525	137	14	C1257931
Disease	Mammary Neoplasms	NCOA3 COL7A1 CD109 SLCO1B1 ZEB2 MEIS1 EEF2 NSUN6 KMT2D CSF3 TLE3 SETBP1 ITSN2 TOX3	1.80e-07	527	137	14	C1458155
Disease	testosterone measurement	NCOA6 MIA3 AMER1 ASCL5 WDR81 LAMB3 SLCO1B3 NAA38 SLCO1B1 RUVBL2 OPHN1 TYK2 PNMA6F ARID1B BBX GTF3C2 RTL9 ZFHX3 MED23 SPOCD1	1.87e-06	1275	137	20	EFO_0004908
Disease	Neurodevelopmental Disorders	TCF4 TRIO CDC42BPB ITPR1 ARID1B SETBP1	4.91e-06	93	137	6	C1535926
Disease	Paranoia	TCF4 TYK2 DNAH8	1.57e-05	11	137	3	C1456784
Disease	HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC	SLCO1B3 SLCO1B1	2.14e-05	2	137	2	C4016905
Disease	Rotor Syndrome	SLCO1B3 SLCO1B1	2.14e-05	2	137	2	C0220991
Disease	Rotor syndrome	SLCO1B3 SLCO1B1	2.14e-05	2	137	2	cv:C0220991
Disease	HYPERBILIRUBINEMIA, ROTOR TYPE	SLCO1B3 SLCO1B1	2.14e-05	2	137	2	237450
Disease	Bladder Neoplasm	HDAC4 FBXW8 KMT2D CSF3 NCAN CHD6	5.06e-05	140	137	6	C0005695
Disease	Malignant neoplasm of urinary bladder	HDAC4 FBXW8 KMT2D CSF3 NCAN CHD6	5.26e-05	141	137	6	C0005684
Disease	colorectal cancer (is_marker_for)	AMER1 EEF2 PBRM1 CTPS2 BARHL2 ZFHX3	9.55e-05	157	137	6	DOID:9256 (is_marker_for)
Disease	Colorectal Carcinoma	COL7A1 CD109 LAMB3 SLCO1B3 ZEB2 ACSL4 MLH3 TOMM40L TP63 SETBP1 SNX8 DNAH8	1.11e-04	702	137	12	C0009402
Disease	calcium measurement	NCOA6 HDAC4 CD109 WDR81 ITPR1 ARID1B BBX TLE3 RTL9 SNX8 ZFHX3	1.75e-04	628	137	11	EFO_0004838
Disease	triacylglycerol 52:6 measurement	LY6G5C BBX NCAN	2.09e-04	25	137	3	EFO_0010418
Disease	anti-human herpes virus 7 antibody measurement	BCL9L TBX21	2.12e-04	5	137	2	EFO_0011038
Disease	bilirubin metabolic disorder (implicated_via_orthology)	SLCO1B3 SLCO1B1	2.12e-04	5	137	2	DOID:2741 (implicated_via_orthology)
Disease	gamma wave measurement	NRG2 GIT2	2.12e-04	5	137	2	EFO_0008388
Disease	Unipolar Depression	PCLO TBX21 BCL9 FREM3 TYK2 ACSL4 CSF3	2.16e-04	259	137	7	C0041696
Disease	breast carcinoma (is_marker_for)	NCOA3 KMT2D AFDN ZFHX3	2.56e-04	66	137	4	DOID:3459 (is_marker_for)
Disease	aggressive behaviour measurement, ADHD symptom measurement	TCF4 NCOA6 XKR6 BBX	2.88e-04	68	137	4	EFO_0007826, EFO_0007860
Disease	lung small cell carcinoma (is_implicated_in)	LAMB3 KMT2D PBRM1	2.95e-04	28	137	3	DOID:5409 (is_implicated_in)
Disease	serum non-albumin protein measurement	MIA3 TBX21 XKR6 CDC42BPB TLE3 TP63 SNX8 AFDN	2.95e-04	361	137	8	EFO_0004568
Disease	congenital heart disease (implicated_via_orthology)	KMT2B ITPR1 KMT2D CHD6	3.04e-04	69	137	4	DOID:1682 (implicated_via_orthology)
Disease	bilirubin metabolic disorder (is_implicated_in)	SLCO1B3 SLCO1B1	3.17e-04	6	137	2	DOID:2741 (is_implicated_in)
Disease	restless legs syndrome (implicated_via_orthology)	MEIS1 MEIS2	5.88e-04	8	137	2	DOID:0050425 (implicated_via_orthology)
Disease	deoxycholic acid glucuronide measurement	SLCO1B3 SLCO1B1	5.88e-04	8	137	2	EFO_0800575
Disease	hand, foot and mouth disease, illness severity status	HDAC4 XKR6	7.54e-04	9	137	2	EFO_0007294, EFO_0007863
Disease	hexadecenedioate (C16:1-DC) measurement	SLCO1B3 SLCO1B1	7.54e-04	9	137	2	EFO_0800562
Disease	interferon alpha/beta receptor 1 measurement	ITSN1 TYK2	7.54e-04	9	137	2	EFO_0021850
Disease	X-21467 measurement	SLCO1B3 SLCO1B1	7.54e-04	9	137	2	EFO_0020007
Disease	prostate cancer (is_marker_for)	NCOA3 KMT2B SLCO1B3 EEF2 KMT2D	8.26e-04	156	137	5	DOID:10283 (is_marker_for)
Disease	unipolar depression, bipolar disorder	CACNA1E TCF4 PCLO NCAN SETBP1	8.26e-04	156	137	5	EFO_0003761, MONDO_0004985
Disease	response to simvastatin, myopathy	TBX21 XKR6 SLCO1B1	9.17e-04	41	137	3	EFO_0004145, GO_1903491
Disease	alopecia	TCF4 HDAC4 OPHN1 ZNF462 BBX SETBP1	9.41e-04	241	137	6	MONDO_0004907
Disease	Adenocarcinoma of large intestine	PAK5 CDC42BPB TYK2 MLH3	1.06e-03	96	137	4	C1319315
Disease	Intellectual Disability	CACNA1E HDAC4 TRIO MEIS2 ZNF462 SETBP1 MED23 MN1	1.19e-03	447	137	8	C3714756
Disease	total blood protein measurement	NCOA3 SLCO1B1 KMT2D BBX TLE3 TP63 SNX8 AFDN	1.22e-03	449	137	8	EFO_0004536
Disease	Psychotic Disorders	TCF4 PAK5 BCL9 PBRM1	1.28e-03	101	137	4	C0033975
Disease	Leukemia, Myelocytic, Acute	TRIO CSF3 SETBP1 ENAH MN1	1.31e-03	173	137	5	C0023467
Disease	glycochenodeoxycholate glucuronide (1) measurement	SLCO1B3 SLCO1B1	1.61e-03	13	137	2	EFO_0800474
Disease	colon carcinoma (is_marker_for)	SLCO1B3 KMT2D	1.61e-03	13	137	2	DOID:1520 (is_marker_for)
Disease	Skin Abnormalities	ZNF469 TP63	1.61e-03	13	137	2	C0037268
Disease	sitting height ratio	TCF4 ARID1B ITSN2	1.73e-03	51	137	3	EFO_0007118
Disease	Bipolar Disorder	TCF4 PCLO DBN1 BCL9 ITPR1 PBRM1 NCAN DNAH8	1.79e-03	477	137	8	C0005586
Disease	diffuse large B-cell lymphoma	CDC42BPB ITSN2	1.88e-03	14	137	2	EFO_0000403
Disease	Situs ambiguus	BCL9L ZIC3	2.16e-03	15	137	2	C0266642
Disease	response to statin, LDL cholesterol change measurement	SLCO1B1 ZNF98	2.16e-03	15	137	2	EFO_0007804, GO_0036273
Disease	X-17654 measurement	SLCO1B1 HSD17B4	2.16e-03	15	137	2	EFO_0800784
Disease	Pontoneocerebellar hypoplasia	AMPD2 PCLO	2.46e-03	16	137	2	cv:C1261175
Disease	Multiple congenital anomalies	TP63 SETBP1	2.78e-03	17	137	2	C0000772
Disease	sphingomyelin 14:0 measurement	PAK5 ZFHX3	2.78e-03	17	137	2	EFO_0010390
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	KMT2B TRIO	2.78e-03	17	137	2	DOID:0060307 (is_implicated_in)
Disease	chronotype measurement	TCF4 HDAC4 THOC3 MEIS1 MEIS2 ZNF462 RNF123 KMT2D CSF3 BARHL2 MGAT5B	2.79e-03	882	137	11	EFO_0008328
Disease	Acute Myeloid Leukemia, M1	TRIO CSF3 ENAH MN1	2.79e-03	125	137	4	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	TRIO CSF3 ENAH MN1	2.79e-03	125	137	4	C1879321
Disease	obesity (implicated_via_orthology)	TCF4 ITPR1 TYK2 ZFHX3 HSD17B4	3.37e-03	215	137	5	DOID:9970 (implicated_via_orthology)
Disease	leukemia (implicated_via_orthology)	MEIS1 MEIS2	3.47e-03	19	137	2	DOID:1240 (implicated_via_orthology)
Disease	neuroticism measurement	CACNA1E TCF4 PCLO XKR6 ATF6B ST13 ITPR1 CTPS2 BBX ENAH TOX3	3.51e-03	909	137	11	EFO_0007660
Disease	corneal hysteresis	TCF4 ZNF469	3.85e-03	20	137	2	EFO_0010066
Disease	Craniosynostosis	ZNF462 MN1	3.85e-03	20	137	2	C0010278
Disease	lung non-small cell carcinoma (is_implicated_in)	ARID1B KMT2D PBRM1 ZFHX3	4.08e-03	139	137	4	DOID:3908 (is_implicated_in)
Disease	Nonorganic psychosis	TCF4 PAK5 PBRM1	4.10e-03	69	137	3	C0349204
Disease	HbA1c measurement, response to sulfonylurea	SLCO1B1 TOX3	4.24e-03	21	137	2	EFO_0004541, EFO_0007922
Disease	Malignant neoplasm of liver	TCF4 TRIO CSF3 TOX3	4.40e-03	142	137	4	C0345904
Disease	Liver neoplasms	TCF4 TRIO CSF3 TOX3	4.40e-03	142	137	4	C0023903
Disease	biological sex	TCF4 ITSN1 BARHL2 SETBP1 CCDC33	4.48e-03	230	137	5	PATO_0000047

Protein segments in the cluster

Peptide	Gene	Start	Entry
PATRGAQMGLAPMEG	AGRP	16	O00253
AQMGLAPMEGIRRPD	AGRP	21	O00253
AGDFDGMSMDLPLPP	AFDN	1376	P55196
LLGGNVRMMLSGGAP	ACSL4	431	O60488
LGQEMMGSLELGPEA	EXOC3L1	346	Q86VI1
MAEMGGLEDLPQPRG	ARHGEF18	841	Q6ZSZ5
MPMGAAERGAGPQSS	ASCL5	1	Q7RTU5
DPTQMGGLSMLLLAG	BBX	201	Q8WY36
PMLSASGLPLGSMGE	CCDC33	796	Q8N5R6
PGPGMMCGAVNNLLS	CACNA1E	2291	Q15878
FMPAMNAVLGSGVPL	BPIFB4	576	P59827
MRPLGPSVMGLAAGV	AMER1	656	Q5JTC6
PNDMEPDGMGSSRKG	GIT2	596	Q14161
ILANMMNGGPAARSG	APBA2	596	Q99767
CGAVPLGRMPSAGMQ	ARID1B	961	Q8NFD5
EPSTMPGDLGLGLRM	AMPD2	311	Q01433
DMGLMNAIGLQPRNP	AMBRA1	1081	Q9C0C7
GMAGMPGLNEILSDP	ST13P5	306	Q8NFI4
GMAGMPGLNEILSDP	ST13	306	P50502
PLISARFGMGSMPNL	ITSN2	111	Q9NZM3
IAMQLPVLGDGMLGD	INTS7	456	Q9NVH2
PSNMGVIFGPTLMRA	OPHN1	521	O60890
AGNMPRQLEMGGLSP	OFD1	831	O75665
RQLEMGGLSPAGDMS	OFD1	836	O75665
DGQQHMGIRAPGPMS	MEIS1	361	O00470
SRSGSGLQEPMMPFG	PAK5	286	Q9P286
MRFMAGPAGSQSLGP	LY6G5C	1	Q5SRR4
PLQGPVDGLVSMGSM	PBRM1	1496	Q86U86
SEQPMMGLSNLSPGP	FAM156A	36	Q8NDB6
NMAFTGGLDPPMGDA	HDAC4	891	P56524
SMAMGTVPGQAPRLA	LYSMD4	261	Q5XG99
LRGGGFLPMTPMAAA	ITPR1	946	Q14643
PTAMIPEAMGSGQQL	HIPK1	776	Q86Z02
HMGIRPAGLQSMPGD	MEIS2	376	O14770
LLGGDMDMGNPGTLS	TCF4	126	P15884
ANSLERMGPAMGPAL	HNRNPM	586	P52272
CMGPVMSGNILVGPE	DSG4	986	Q86SJ6
MAEPTGLLEMSELPG	EID2B	1	Q96D98
MPPGAGLMERIQAIA	MGAT5B	111	Q3V5L5
VMPGEGDLPQMEVGS	EID1	21	Q9Y6B2
SDSPPNLMVSGNMDG	FBXW8	441	Q8N3Y1
ESPLSPVGQPMGMAR	PCLO	4361	Q9Y6V0
GGLPARMGSAVDMAP	PNMA6F	511	A0A0J9YX94
MMGEAAVAAGPCPLR	KPTN	1	Q9Y664
GSLDSPSGMLMNPVE	MLH3	996	Q9UHC1
PSGMLMNPVEDATGD	MLH3	1001	Q9UHC1
MAPTFLLVGMPGLSG	OR51S1	16	Q8NGJ8
NMAMPLGERITGGFL	PCED1A	181	Q9H1Q7
TLAQALGMNMGGAPA	DNAH8	1831	Q96JB1
GGMRRDPAPGFSMLL	NRG2	91	O14511
GNGIMRIPLPGTNCM	MED23	501	Q9ULK4
GLRAAMGPGISRMND	PGM2	61	Q96G03
RKRPMANGLAMAGSP	SLC16A7	141	O60669
ASMPLSPGGQMEEVA	KMT2B	816	Q9UMN6
LGSGNLRMAVMLPEG	MOB1B	36	Q7L9L4
PRGPGSPAEDLMFME	DBN1	411	Q16643
GPGDGMQVLMDLPLS	CDC42BPB	1596	Q9Y5S2
LLDAPCSGMGQRPNM	NSUN6	321	Q8TEA1
PAMRMEAGEAAPPAG	KCTD17	6	Q8N5Z5
PISGADLHGMLEMPD	DSG1	871	Q02413
GELVIPNLMANFGPM	NSUN4	361	Q96CB9
GMSAGLPLGALPEML	TM7SF2	116	O76062
MEAGFPMASGPGIIR	NCOA6	161	Q14686
AGEPMDLGELVGMTP	PRPF19	156	Q9UMS4
PMAGDMNGLSPTQAL	TP63	511	Q9H3D4
SGPGRSGMALMEVNL	CD109	1306	Q6YHK3
PAMMVNLRACSAPGG	C2CD2L	251	O14523
DQHLGPGAMVMPQAA	PRMT7	501	Q9NVM4
IVADSPSGMGPLFMN	CHD6	2456	Q8TD26
PLFMNGLIAGMDLVG	CHD6	2466	Q8TD26
LGFAGMNEMVAPRIG	FRMPD1	1316	Q5SYB0
AMFLGMDLPGLNLPD	FRRS1	496	Q6ZNA5
MMGGGLAEIPGLSIN	HSD17B4	386	P51659
RLPGFAGMINSEMEG	BCL9	561	O00512
MASPAMLGNVESGGP	BCL9	956	O00512
TLMSNPAAAVGMIPG	BCL9	1346	O00512
GMGGIASMPPLTAVA	ITSN1	116	Q15811
RGPMDVQDPMQLRGG	BCL9L	581	Q86UU0
LMGPQGLSPEEMARV	BCL9L	806	Q86UU0
MAGTRGLMLLGPGPV	CASC2	1	Q8IU53
MDTDMAGQLPLGPHL	FAM131A	206	Q6UXB0
MPEPGPRMNGFSLGE	ABHD17C	1	Q6PCB6
SSGSPGMMNGDFRPL	BARHL2	21	Q9NY43
MAGAGPTMLLREENG	NAA38	1	Q9BRA0
ELGMAPALQPTQGAM	CSF3	156	P09919
PMPAGMLIERSSDFG	LAMB3	126	Q13751
IRDMPYMDPSGNNLG	COL7A1	1121	Q02388
PLPLGGSGLMEEMSA	ENAH	436	Q8N8S7
ESGPMGNIMIDPVLG	EEF2	196	P13639
SGDDGRMDMPGLVNL	S100A7L2	21	Q5SY68
MAELQLDPAMAGLGG	KCTD2	1	Q14681
RGELAGPLHPAMGMA	ONECUT3	81	O60422
PGASAMPRAAGMVGL	MN1	271	Q10571
MGPERHLSGAPARMA	MEA1	1	Q16626
MMLDDIVSRGRGGPP	KHSRP	206	Q92945
MFGGKPRNMVLSPEG	GPRASP1	1081	Q5JY77
PMMVELLGPEGQDAG	FREM3	266	P0C091
CPPNSLALEGGLGMM	FOXF1	181	Q12946
EMGPDVLVQTMGAPA	KIF13B	1511	Q9NQT8
IAMGMAQALGPDTPF	RUVBL2	86	Q9Y230
SGDPGRLAGFLMQMD	RTL6	106	Q6ICC9
GELSPILMQDMNPGV	RTL9	201	Q8NET4
LDSGAMSTPLMGAPA	RTL9	406	Q8NET4
GKMLSQPMSTQDPGG	RTL9	716	Q8NET4
GEMSLPLMRAPASGE	RTL9	791	Q8NET4
PSEQMGFLISEMGPA	HSF5	531	Q4G112
MAMEIDSRPGGLPGS	ATP6V1B1	1	P15313
MLMGVKPGEDASGPA	RAB11FIP1	466	Q6WKZ4
SNLPPRIMAAGGLQM	AGXT	31	P21549
MTGRAMDPLPAAAVG	SNX8	1	Q9Y5X2
LGDEGQPVLMDLGSM	STK16	156	O75716
GMVGPLAQDPQSPMA	POMT2	726	Q9UKY4
ASPTGDMAVGSPLMQ	TBC1D25	571	Q3MII6
GSMPLSLGQPVMGIN	SYNRG	411	Q9UMZ2
LVMAPPLEEGLGGAM	MIA3	1041	Q5JRA6
EPPLAMAVTEMLGSG	NCAN	521	O14594
SMDGLLAGPTMPQAP	NCOA3	1291	Q9Y6Q9
AGDMIEMQGFGPSLP	SGSM2	431	O43147
MGNMLRGIGETPIVP	SLCO1B1	176	Q9Y6L6
VSGLLQGMMGLLGSP	SLC23A3	171	Q6PIS1
MMKPAGPLGATATRG	SEC24D	41	O94855
MPAMAPNETLSGRGA	ATF6B	621	Q99941
PGCLLPDGSRMMAVA	NLN	456	Q9BYT8
EMPNREPAGMGLNPF	ZIC3	26	O60481
MPEHNPGNLGGTMRL	CTPS2	436	Q9NRF8
VEGLTSRGPPMMGAG	XKR6	196	Q5GH73
MAAAVAGMLRGGLLP	MRPL10	1	Q7Z7H8
MGPRGAINMGDAFSP	PSPC1	396	Q8WXF1
MAQRPMQALAVGGPL	RNF123	651	Q5XPI4
LQNMEGASSMPGLSP	SPOCD1	26	Q6ZMY3
VGPGPALMLRGMEGA	PFAS	1211	O15067
MGNMLRGIGETPIVP	SLCO1B3	176	Q9NPD5
MAVPAAAMGPSALGQ	THOC3	1	Q96J01
LPSSPGLLMVGEDMQ	nan	211	A8MX80
MSVEDGGMPGLGRPR	SLC35A4	1	Q96G79
NMPSNIGAPLISSMG	TOX3	406	O15405
GMDPIGIMASALRTP	TLE3	346	Q04726
HGMEMLSRLPFPAGG	ZNF469	496	Q96JG9
LPSSPGLLMVGEDMQ	nan	181	A8MV72
MPGTPGSLEMGLLTF	ZNF91	1	Q05481
CPNMTAGDGPLVIMG	WFIKKN1	491	Q96NZ8
LPSSPGLLMVGEDMQ	nan	211	Q8N9G6
LPSSPGLLMVGEDMQ	nan	211	A8MUI8
MGNTLGLAPMGTLPR	TOMM40L	1	Q969M1
MPGPLGSLEMGVLTF	ZNF98	1	A6NK75
PPTAAMMRGVEGPQG	ZNF462	1151	Q96JM2
CRGMAPNGLPNHIMA	GTF3C2	291	Q8WUA4
DASGAGPGPKMVAMQ	VAV2	581	P52735
VSQGPLMGLNPRGMQ	WDR33	771	Q9C0J8
PSAPALGGESDMLGM	TRAPPC10	886	P48553
VGMEAPLLGFPTMNS	ZEB2	441	O60315
HLQGPVSMGLGDMQP	SETBP1	1116	Q9Y6X0
VSMGLGDMQPSLNPP	SETBP1	1121	Q9Y6X0
MLTGTEPMPGSDEGR	TBX21	11	Q9UL17
LQMSGPEVPMGAERG	WDR81	826	Q562E7
SASLRVLGPGMDGIM	TRIO	2771	O75962
GSKPVGDGAQPMAAM	TYK2	11	P29597
AGPMAAMTPALVGGE	ZFHX3	896	Q15911
AMTPALVGGEIPLDM	ZFHX3	901	Q15911
GLGLKPGQSMMGSRD	KMT2D	3151	O14686